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Abstract 
Rhodamine based dyes have grown in popularity for use as pH sensors in biological systems due 
to their sensitive and rapid response to changes in pH. However, these rhodamine dyes typically 
fluoresce at levels which are too acidic for most biological system. Since the pH at which the 
dyes fluoresce is a function of the steric and electronic effects of different substituents, different 
di-ortho Rhodamine B (RB) and Rhodamine 6G (R6G) derivatives were synthesized. 
Computational models were also used in order to develop a better understanding of the steric and 
electronic interactions which drive the pH-dependent fluorescence of rhodamine dyes. As a 
result of titrations of the RB and R6G series, a working equation for use in predicting the pKa of 
a derivative based on the substituents was drafted using both steric and electronic parameters. 
Ultimately, the pH response was tuned enough to allow for the development of a rhodamine pH 
probe capable of responding at a high enough pH for biological applicability. This pH probe was 
incorporated into conjugated polymer nanoparticles as proof of concept for a possible vector 
pathway for future biological studies.   
2 
 
Introduction 
 pH expression in biological systems varies based on the location within the cell as 
different organelles require different pH levels for optimum function. A disruption in this pH 
level can cause cell death or a change in the function of the cellular system.
1
 As a result of these 
changes, pH plays an important role in certain cell dysfunctions as occurs when pH regulation in 
the lysosome fails. Autophagy, the process by which cells degrade waste and dispose of damaged 
organelles, requires an acidic pH; a problem in the regulation of lysosomal pH can contribute to 
neurodegeneration.
2
 Presenilin 1 assists in the acidification of the lysosome which enables the 
digestive enzymes to work.
3
 Mutations in this gene and other lysosomal proteins can all 
contributed to an abnormal increase of pH. Lysosomes typically have a pH of about 4.7 as 
opposed to the typical cellular environment, which is firmly in the neutral region around 7. This 
pH regulation plays an important role in several disease states such as Alzheimer’s disease, 
Parkinson disease, and prototypical lysosomal storage diseases.
2
 
 While diseases involving the lysosome are usually characterized by an increase in pH, 
another cellular dysfunction characterized by unusual pH levels is cancer, in which the pH of the 
cell and surroundings is abnormally low. Due to the large demand for energy needed for 
continuous growth and division, cancerous cells rely upon anaerobic metabolic processes, even 
when in the presence of oxygen. This reliance upon glycolysis is called the “Warburg effect.” A 
byproduct of glycolysis is lactic acid which, in addition to the poor blood flow, results in a 
decrease in extracellular pH from 7.5 to approximately 6.4-7.1. Less of a change is observed in 
the intracellular pH. The decrease in the extracellular pH benefits the cancer cell in two ways: 
one, the lower pH allows the cell to pass relatively unnoticed by the body’s immune system4, and 
two, the acidic environment further encourages the spread of cancerous cells throughout the 
3 
 
body, a process known as metastasis. Studies have found that correcting the pH can inhibit 
cancerous growth and increase the effectiveness of some chemotherapeutic drugs.
5
 
 Fluorescent pH probes are growing increasingly common for studying cancerous cells as 
they are easy to use, highly specific, and highly selective.
6
 Since they can respond quickly to pH 
changes within a cell and the fluorescent imaging techniques are nondestructive, fluorescent pH 
probes are particularly well suited for studying cellular systems.
7
 However, while there are 
several fluorescent pH probes designed for a neutral pH range (pH 7), there are fewer for use in 
the acidic region (pH 4.5-6).
8
 Many probes that do work in this region are not well suited to in 
vivo imaging. For example, some are hydrophobic. Probes designed for in vivo imaging can be 
used in the detection of cancers by attaching to cancer-targeting antibody and activating in the 
lysosome, where the fluorescence is triggered by the more acidic pH. Here, a reversible probe is 
particularly beneficial as when cell death occurs the pH becomes more neutral and the probe 
loses the fluorescence signal. As a result, the probe could be used to monitor the effect of 
treatment on cancer cell death in real-time.
9
 
 Another method which uses pH-sensitive probes in cancer detection is the injection of the 
probe into the body. In this process, the fluorescence is most intense on the edges of the tumor as 
a result of the decreased extracellular pH and possible difficulties encountered by the probe in 
penetrating deeper into the tumor. Such a distribution would aid surgeons in determining the 
boundaries of cancerous tumors to ensure the removal of the entire tumor, thereby reducing the 
chance of remission. Though, as stated above, the extracellular pH of cancerous cells is about 
6.4-7.1, dyes that fluoresce at lower pH values still had good fluorescence in and around tumors 
which makes our goal of a probe in the 4.5-6 range still valid.
4
 Rhodamine spirolactams (RSLs) 
have all the properties needed for in vivo imaging, but they typically have pKa values below the 
4 
 
acidic region. One common RSL, rhodamine B, has a pKa of 3.2.
10
 Therefore, we developed 
several new probes by modifying rhodamine dyes through the addition of various substituent 
groups. 
 Fluorescence is best explained through use of a Jablonski diagram (Figure 1). The blue 
line demonstrates the excitation of the electron into an excited singlet state. This excitation is 
caused by the absorption of energy in the form of light. The electron can then relax within the 
excited singlet state as shown by the dashed line. When the molecule returns to the ground state, 
as shown by the red line, it emits a photon, releasing the absorbed energy as light. This process is 
known as fluorescence. Not all compounds are fluorescent; the return to the ground state must be 
spin allowed. In other words, the excited state electron must be paired to a ground state electron 
of opposite spin.
11
 The absorption of the light produces absorption spectra (Figure 2). Both these 
spectra and the fluorescence spectra typically mirror each other but the latter are observed at 
higher wavelengths. This means that the emission energy is less than the excitation energy, with 
the difference between them called the Stokes’ shift. Energy can be lost by internal conversion, 
the transition of the electron from one electronic energy level to another (shown by the first 
dotted line in Figure 1), or by vibrational relaxation within the excited state when the electron
 
Figure 1. Jablonski diagram depicting 
absorption in blue and fluorescence in red. 
 
Figure 2. Absorption (left) and fluorescence 
(right) spectra. 
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Figure 3. Rhodamine dye structures (RB and R6G) 
 
 
Scheme 1. Rhodamine spirolactam ring opening mechanism in rhodamine B. 
loses energy to other vibrational states such as the kinetic state (shown by the second dotted 
line). This process occurs more quickly than fluorescence. Stokes’ shifts can also be affected by 
solvent effects and other interactions.
11
 
 RSLs are amino isologs of fluorescein dyes.
7
 Whereas fluoresceins fluoresce under basic 
conditions, RSLs are fluorescent in acidic environments, which make them ideal for the purposes 
outlined earlier in the paper.
12
 The specific RSLs used to develop the pH probes described in the 
following paper were rhodamine B (RB) and rhodamine 6G (R6G) (Figure 3). These dyes 
consist of two planes, one containing the xanthene ring and the other contraining the spirolactam 
ring. The addition of acid protonates the carbonyl on the spirolactam ring, thereby opening the 
ring and extending the conjugation of the molecule.
6
 It is this conjugation which results in 
fluorescence. Since rhodamines also possess colorimetric properties this ring opening also marks 
the change of the compound from colorless to bright pink. Since the opening of the spirolactam 
ring controls the fluorescence it is the ring modified in order to influence the pKa of the 
rhodamine derivative.
6
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 Since RSL probes have a second colorless form in addition to the two forms, one 
colorless and one colored, assumed by the Henderson-Hasselbach equation (1), the Henderson-
Hasselback-type mass action equation (2) is instead used to determine pKa values.
13
 
           
    
      
      (1) 
              
      
      
     (2) 
The pKa is based on the fluorescence intensity (I), with Imax and Imin as the maximum and 
minimum fluorescence intensities respectively.
6
 This intensity is based on the pH but also 
depends on the molecule used and the solvent. RSL derivatives demonstrate more intense 
fluorescence in polar protic solvents, like the ethanol-water mixture used in the fluorescence 
titrations described later. Protic solvents provide a more stable environment for the ring opening 
due to their H-bonding interactions with the acyclic amino groups. The polar properties of the 
protic solvents are also important to the intensity, as greater polarity favors an open-ring 
structure by separating the intramolecular charges.
14
 These solvents effects are less important for 
pH probes used in cellular environments, where the solvents cannot be varied. Thus, substituents 
would have the most impact on the fluorescence intensity of those probes. I will discuss the 
effects of the substituents on the intensity later in the paper, however it is important to note that 
rhodamine 6G has a more intense fluorescence than rhodamine B.
12
 This difference in intensity 
is explained by R6G’s larger quantum yield, 0.95, as compared to RB’s quantum yield of 0.65 
when measured in ethanol at room temperature.
15
 Quantum yields are the number of emitted 
photons compared to the number of absorbed photons
11
: 
   
                         
                 
 
 
      
    (3) 
Γ represents the fluorescence rate constant while knr is the rate constant for all nonradiative 
decay, the return to the ground state by emitting energy in the form of heat instead of as a 
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photon. Thus, the quantum yield is large if the rate of nonradiative decay is less than the rate of 
fluorescence. Substances with the largest quantum yields, those near 1, therefore have the most 
intense fluorescence.
11
 
 As mentioned previously, RSLs have the properties needed for use in living cells. They 
possess high photostability with a high quantum yield and long excitation wavelength, so that 
their use as a sensor in biological systems is sensitive and specific. That means their fluorescence 
is a response based solely on the pH of the environment.
6
 They are also capable of crossing the 
cell membrane without requiring the use of cell loading techniques that might damage the cell.
1
 
Once in the cell, rhodamine based sensors are selective for lysosomes as a result of the lysosomal 
acidic environment.
14
 Additionally, several experiments have shown that rhodamine probes are 
not prone to interference with biologically important species in the cell system and therefore 
have low cytotoxicities when used at low concentrations.
1,12
 
 Within this paper, I will examine the effects of substituents on the pKa of rhodamine B 
and rhodamine 6G derivatives. We are interested in determining what types of substituents will 
raise the pKa of these molecules into the desired acidic region so that these probes can then be 
used in living cells. The key properties of the substituents we are varying are their steric and 
electronic properties. Prior experiments conducted on RB derivatives with para substituted R 
groups (Figure 4) by Will Czaplyski, a former member of the Harbron lab group, demonstrated 
that the electronic substituent effects did not influence the pKa; the substituent electronics only 
affected the kinetics of the spirolactam ring opening.
13
 Electron-withdrawing substituents had the 
fastest reaction rate with a more intense fluorescence. All para derivatives had similar pKa 
values with an average of 4.14 ± 0.04. However, we later determined that switching pH probes  
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Figure 4. Rhodamine para substituents (R= -OCH3, -t-C4H9, -CH3, -H, -Cl, -CF3, -C=N, -NO2) 
 
attached to the pH meter without calibrating the instrument had contributed to error in some 
cases. This lack of calibration in addition to the fact that only one titration trial was used to 
determine pKa resulted in some uncertainty with regards to the results recorded in this paper. A 
repeat set of four titrations of RB-4Cl gave a pKa of 4.21 ± 0.01 as opposed to the previously 
reported 4.10 value. In addition, RB-A was retitrated for an increased pKa value as discussed 
later in the paper. We may be able to assume that all the data points are still within a narrow 
distribution, just slightly shifted due to inaccurate pH readings during the titration. 
In comparison, the single titration of RB-2,6-Cl2-4-NO2 (RB-DCNA) had a value of 5.43 
which was far more consistent with the three additional titrations for a final pKa of 5.46 ± 0.03. 
This particular probe was developed to test the theory that sterically bulky groups would increase 
the pH and was consistent with Lin Yuan’s findings.12,13 Yuan supported his theory by attaching 
1-adamantanamine to the amide moiety of both R6G and RB for pKa values of 6.5 and 5.6 
 
Figure 5. Rhodamine B-adamantanamine 
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respectively.
12
 The RB version of this compound is depicted in Figure 5. R6G derivatives tend 
to derivatives tend to fluoresce at higher pKas because the additional methyl group on the 
xanthene ring creates greater steric strain, making the spirolactam ring more likely to open. 
Another set of Yuan’s compounds involved a para substituted R group of –OH (using the same 
model as in Figure 4). This R6G-4OH had a pKa value of 3.2. Unfortunately, the pKa for the RB 
version of this derivative was not reported but if it is less than the R6G-4OH, as is generally the 
case, than there is a para substituent which is inconsistent with Czaplyski’s data. Thus, either 
R6G compounds react differently when para substituted or else the theory that only steric bulk 
influences ring opening in para substituted compounds begins to break down. I will discuss the 
possibility of both these options and the consequences later in this paper in reference to my 
titrations of di-ortho substituted RB and R6G derivatives as well as Mona Rasooly’s titrations of 
mono-ortho substituted RB derivatives (Figure 6). Grace Purnell synthesized several of the RB 
di-ortho compounds and Grace Taumoefolau synthesized the majority of the R6G versions. 
Additionally, I will use Purnell’s calculations of the optimized structure for the RB di-ortho 
derivatives with the exception of RB-diethoxyaniline (RB-DEA), which I calculated. 
 
Figure 6. RB and R6G di-ortho substituents and RB mono-ortho substituents 
Rhodamine B di-ortho compounds (R1=Et, R2=H, R3=R4= -H, -Cl, -F, -OEt, -Me, -i-Pr), 
rhodamine 6G di-ortho compounds (R1=H, R2=Me, R3=R4= -H, -Cl, -F, -OEt, -Me, -i-Pr), and 
rhodamine B mono-ortho compounds (R1=Et, R2= H, R3= H, R4= -Cl, -F, -Me, -i-Pr) 
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The goal of this project was to determine the influence of the steric and electronic 
properties of di-ortho substituents on the opening of the spirolactam ring. We tested several  
different numerical measurements of steric bulk and electronics to determine the best model for 
the system. Our original hypothesis based on Czaplyski’s data from the para-substituted RB set 
was that steric bulk would increase the pKa but that the electronic properties of the substituent 
would not impact the pKa in any way. We hoped to be able to successfully synthesize a dye with 
a pKa in the acidic region and then be able to incorporate that dye onto a conjugated polymer 
nanoparticle (CPN). CPNs can serve as a vector for transporting drugs, and in this case dyes, into 
a cell. They have low cytotoxicity and the combination of their large quantum yield and 
photostability makes them ideal for in vivo imaging.
16
 CPNs have been used in imaging cancer 
tumors previously and can be conjugated to attach antibodies targeting cancer cells as a means of 
transporting the rhodamine dyes to those cells for imaging as otherwise our dyes would not 
specifically target them.
17
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Results and Discussion 
Section I. Synthesis of di-ortho RB and R6G derivatives  
 Synthesis of di-ortho substituted RSL derivatives is challenging due to the steric 
interactions. The yields of RB reactions are substantially lower (8-57%) than Czaplyski’s percent 
yields for his para-substituted RB compounds (40-94%). R6G derivatives have even lower 
yields (5-18%) due to their increased reactivity, the result of the hydrogen groups off of the 
xanthene nitrogens and the increased steric hindrance provided by the xanthene ring methyl 
groups. R6G based compounds also tended to interact more with the silica type column due to 
their greater sensitivity to the acidic column and therefore increased streaking, which caused 
more product to be lost during separation due to bands running together and product remaining 
on the column. Hereafter the RSL derivatives with the di-ortho R groups –H, -F, -Cl, -Me, -OEt, 
and –i-Pr will be abbreviated as RB-A, RB-DFA, RB-DCA, RB-DMA, RB-DEA, and RB-DIA 
respectively with the RB replaced by R6G for those versions of the derivatives. These specific 
side groups were chosen for their range of steric values. 
 The synthesis procedure used in the creation of the RB di-ortho substitutents was 
developed by Grace Purnell. It is similar in nature to the procedure outlined in Czaplyski’s paper, 
but with variations in the duration of reflux, atmosphere, and ratio of reactants.
13
 These 
differences could have also contributed to the small percent yields and would be worth 
investigating further for future synthesis reactions. The synthesis procedure developed for the 
R6G di-ortho substituents was optimized by Grace Taumoefolau based in part on the synthesis 
described by Quinn Best and colleagues in their paper on Anilinomethylrhodamines.
18,19
 
 This section contains a basic summary of the synthesis procedures used to make di-ortho 
substituted RB and R6G derivatives as well as a discussion of their purification. Additionally, I 
12 
 
will detail the differences between the previous procedure used for RB derivative synthesis and 
the current procedure as well as possible modifications and investigations.  
13 
 
A. RB di-ortho derivatives synthesis and purification 
 
Scheme 2. Rhodamine 6G synthesis and derivatives 
R= H(1a), F (2a), Cl (3a), Me (4a), OEt (5a), iPr (6a) 
 A single pot reaction was used for the synthesis of RB di-ortho derivatives, detailed 
above in Scheme 2. RB reacts best under reflux. The phosphoryl chloride (POCl3) and 1,2-
dichloroethane (ClCH2CH2Cl) reacted with the RB to create RB-acid chloride, in which the OH 
group was replaced with Cl. This reaction set up the second step, in which the acid halide’s C-Cl 
bond is broken by the formation of HCl, leaving the amide attached to the RB base. These 
reactions can clearly be split into a multi-step reaction, and indeed we found that splitting up the 
process worked best when synthesizing RB-dinitroaniline (RB-DNA). However, generally the 
RB synthesis worked well with just one step. 
 In a one-step reaction, RB was dissolved in dichloroethane. Next, POCl3 was slowly 
added drop-wise, while swirling. A 3:1 ratio of the aniline derivative to RB was used (1.25 mmol 
of aniline derivative). The aniline was also slowly added drop-wise, while swirling. These 
chemicals formed the mixture to be refluxed. The reaction was run under reflux until a thin-layer 
chromatography (TLC) plate showed evidence of product formation, which typically took about 
twenty-four hours. This product was usually found as a pink band just under a yellow band 
which indicated the presence of unreacted aniline. A UV lamp provided further proof of product 
as the band containing product glowed when the TLC plate was placed under the UV light. In 
14 
 
particular, the product band glowed under the long wave UV light of 365 nm. The solvent used 
for the TLC plates was a mixture of ethyl acetate and hexanes, with ethyl acetate being polar and 
hexanes being non-polar. At times the product band was difficult to discern due to the presence 
of other byproducts. In these cases, the reaction was run until there was no noticeable change in 
the TLC plate from the day prior. A reaction was rarely run longer than three days. 
Unfortunately, starting material was always present so monitoring for the disappearance of the 
starting material was ineffective. The continued presence of starting material does suggest that 
the synthesis could be further streamlined to minimize waste. 
 In the case of the two-step reaction for RB-DNA, RB was dissolved in dichloroethane. 
POCl3 was then added dropwise to the mixture over the course of several minutes. This mixture 
was then refluxed for four hours to produce RB-acid chloride. After reflux, the solution was 
rotovapped until no solvent remained before being redissolved in dichloroethane. A 6:1 molar 
ratio was used of DNA (2.51 mmol) to RB. This ratio was larger than the 3:1 ratio of aniline 
derivative to RB typically used in this type of synthesis. DNA was particularly difficult to attach 
to the RB base, hence the greater excess of aniline to ensure a good conversion. Once the DNA 
was added slowly drop-wise, it was refluxed until the TLC plate showed product (ca. 24 h). This 
two-step reaction was most similar to the synthesis procedure used in the Best paper mentioned 
previously.
18
 
 Czaplyski ran his para-substituted reactions in an argon atmosphere.
13
 This argon is 
intended to keep the reaction dry so as to minimize side reactions, which is of particular 
importance in the R6G derivative synthesis. RB is not as reactive, which is presumably why the 
use of argon atmosphere was unnecessary. Instead, the rubber stopper was used to cover the 
round bottom to reduce exposure to contaminants but this step appeared to have little effect on 
15 
 
the yield. Another difference between the prior procedure and current procedure is the time of 
reflux. Czaplyski only ran his reflux reaction for five hours.
13
 While Yuan and Best both 
performed two-step reactions in their respective papers, Yuan refluxed both steps for six hours 
while Best refluxed the first step for four hours and the second step for twenty-four hours.
12,18
 
The shorter duration of reflux could minimize the chance for byproduct formation, assuming that 
the RB di-ortho derivative is preferentially and rapidly formed. The Best paper still reported high 
yields, however.
18
 Given these findings, I might suggest an investigation comparing a one-step to 
a two-step reaction, particularly since RB-DNA was best synthesized through use of the later 
procedure. It therefore stands to reason that the two-step reaction might have an increased yield; 
addition of the aniline post acid halide formation might also minimize possible interactions 
between the POCl3 and aniline. Additionally, an investigation of reflux duration should be done 
ranging from five hours to twenty-four while monitoring the percent yield and byproduct 
formation. As mentioned above, monitoring the reaction through the presence of the starting 
material is not effective with the current procedure but should the synthesis be improved to the 
point where all the starting material is interacting with the reagents then the disappearance of 
starting material would be the best indication that the reaction has run to completion. 
 The final key difference in Czaplyski’s synthesis procedure was the amounts of reactants 
used. In my synthesis procedure I used 0.42 mmol of RB, 3.22 mmol of POCl3, and 1.25 mmol 
of the aniline derivative except for the RB-DNA synthesis where 2.51 mmol was used. Czaplyski 
used 0.21 mmol of RB, 0.25 mmol of POCl3, and 0.63 mmol of the aniline derivative.
13
 While 
both procedures typically have an excess of aniline at a 3:1 ratio compared to RB, with the 
exception of the RB-DNA synthesis, the ratio of POCl3 to RB is significantly different. 
Czaplyski’s synthesis had a 1.19:1 ratio of POCl3 to RB, an approximately equivalent ratio. My 
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synthesis on the other hand had a greater excess of POCl3 for a 2.68:1 ratio. I believe that 
Czaplyski’s ratio makes more sense synthetically as POCl3 is highly reactive and so could be 
causing byproduct formation when in an excess. Such formations could contribute to our lower 
product yields. Theoretically, one mole of POCl3 should react with one mole of RB to form RB-
acid chloride so a 1:1 ratio would be best. This aspect of our synthetic procedure should be 
modified. Czaplyski also added the POCl3 after the addition of the aniline to the RB solution but 
I feel that, based on the preference for the two-step reaction in the literature, the formation of 
RB-acid chloride prior to the addition of the aniline was best.
13
 However, this change in the order 
of reactant addition may be worth investigating. 
 The workup for RB derivatives after the solution was removed from reflux involved 
diluting with chloroform before washing with acid, base, and brine in a separatory funnel. 
Anhydrous magnesium sulfate was added to the organic layer. Magnesium sulfate clumps in the 
presence of water so it was added to the mixture until the mixture gained a snow globe effect 
when swirled, that is it was added until the magnesium sulfate stopped clumping when added. 
Then the mixture was filtered and concentrated under reduced pressure to form the crude 
product. A 
1
H NMR spectrum of this mixture was used to confirm the presence of product. 
 Flash column chromatography was used to separate the desired product from the 
byproducts and starting material. Prior to beginning a column, a ratio of ethyl acetate to hexanes 
was decided upon by testing several proportions to determine which gave the best separation of 
bands on the TLC plate. A ratio of 80:20 of ethyl acetate to hexanes (EtOAc:Hexanes) provided 
the quickest retrieval of the product, that is the highest retention factor (Rf) value. However, it 
also tended to have the least amount of separation. The lower the ratio of EtOAc:Hexanes, the 
greater the separation but the longer it took for the product band to exit the column. Therefore a 
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ratio between 40:60 EtOAc:Hexanes and 60:40 EtOAc:Hexanes was usually selected as the 
starting eluent for the column. This gradient could be increased gradually once a good degree of 
separation had been achieved within the column in order to speed the elution. Thus, the gradient 
was usually increased once the excess aniline, which had the highest Rf value of all the bands, 
was eluted from the column. The product band was generally the band immediately following 
the aniline band, but this was not always the case. 
 The stationary phase of the column chromatography was silica gel. Since silica gel is 
somewhat acidic, product would open on the column, which could result in the product band 
getting ‘stuck’. The interactions between the silica and acid-sensitive RB derivative could slow 
the band to the point where it would not move through the column or would ‘smear’ which 
would draw out the width of the band and therefore increase the risk of byproduct bands running 
into the product band. The regular addition of triethylamine, a base, was needed to keep the 
product closed and therefore moving smoothly through the column. The column was then packed 
using a slurry method in which the EtOAc:Hexane solvent was added to dry silica in an 
Erlenmeyer flask. This slurry was then added to the column. Extra solvent was added before air 
was run through the column to increase the flow rate. Just when the solvent was about to enter 
the stationary phase, the air was stopped and the stop-cock closed. About a millimeter of sand 
was added to the top of the column. The crude product was dissolved in chloroform and pipetted 
into the column in a manner which ensured that the sand layer was evenly saturated with the 
product containing solution. Solvent could then be added, taking care not to disturb the sand 
layer. Air was an effective means of pushing the solvent through the stationary phase at a faster 
rate but it was necessary to watch the column carefully to make sure that no parts of the 
stationary phase began to dry out. The bands exiting the column were collected in test tubes, 
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which were then tested on TLC plates to ensure there was only one compound present in the 
band. Product usually appeared as a pink dot on the TLC plate and glowed under UV light as 
mentioned above. TLC was used to confirm the start and end of each band. The test tubes 
containing that band were combined into a round bottom flask and rinsed with acetone into that 
same round bottom in order to gather as much product as possible. The round bottom was then 
concentrated in vacuo to form a powder so that an NMR could be used to confirm that the band 
was indeed product. Sometimes multiple columns needed to be run on a compound to obtain a 
pure product. I found that the high vacuum line worked better than the rotovap to further dry the 
product at this stage. 
 Best used an alumina column, which is more basic in nature than silica gel, in order to 
prevent reactions between the desired product and stationary material.
18
 However, Grace 
Taumoefolau found that, at least in the case of R6G di-ortho derivatives, the alumina column 
interacted with the product in such a manner that it changed the structure, possibly as a result of 
oxidizing an amine on the xanthene rings.
19
 While this process is less likely to occur with RB 
derivatives due to the lack hydrogen on the amines of the xanthene ring plane and alumina 
columns were successfully used with R6G derivatives by Best, I would still continue to use silica 
gel. As long as the product is kept in the closed form, RB does not appear to interact too much 
with the silica gel and Czaplyski was still able to get high product yields using this type of 
column.
13
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B. R6G di-ortho derivatives synthesis and purification 
 
Scheme 3. Rhodamine 6G synthesis and derivatives 
R= H(1b), F (2b), Cl (3b), Me (4b), OEt (5b), iPr (6b) 
 As shown in Scheme 3 above, the synthesis for R6G derivatives was somewhat more 
involved than for their RB counterparts. RB needs the energy from heat during reflux to react; an 
attempted synthesis of an RB di-ortho derivative at room temperature revealed no product 
formation after a day. Unlike RB, R6G-acid is sensitive to heat and water in the air, therefore it 
has to be run under room temperature or cold conditions with measures taken to ensure the entire 
process remains as dry as possible. Grace Taumoefolau optimized the R6G synthesis procedure 
into the following process to minimize byproduct formation.
19
 
 In the first step of the reaction, R6G-acid was synthesized. R6G, NaOH, EtOH (ethanol), 
and de-ionized water (DI H2O) were combined in a round bottom and refluxed for approximately 
twenty-four hours before leaving to stir for two days. The round bottom was then placed in an ice 
bath where 6 M HCl was slowly added to the solution before the mixture underwent Buchner 
filtration. R6G-acid was obtained in the form of a sticky red solid. During this synthesis the 
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condenser should be kept greased for the reflux stage as otherwise the round bottom will stick to 
the condenser. 
 For the next step in the procedure, molecular sieves were added to a round bottom. The 
top was then covered with rubber stopper and needle to vent after adding a stir bar. The round 
bottom was then flame dried while connected to argon gas. The heat from the flame activated the 
molecular sieves. The round bottom was left to cool as R6G-acid from step one was massed out 
into a small Erlenmeyer. The R6G-acid was crushed with a spatula and anhydrous 
dichloroethane was added before sonicating. 10 mL of anhydrous dichloroethane was added to 
the round bottom while stirring, before the 20 mL from the Erlenmeyer was added. Another 20 
mL of dichloroethane was added to the Erlenmeyer and once again the R6G-acid was crushed 
prior to sonicating. This solution was then added to the round bottom. The remaining R6G-acid 
was crushed as much as possible, then 10 mL dichloroethane was added to it and the mixture was 
sonicated. This final batch was added to round bottom. Since R6G-acid is so sticky, there was 
always some left over in the Erlenmeyer so it was best to err on the side of too much R6G-acid 
than too little for the sake of product yield. It was also important to attempt to dissolve as much 
R6G-acid as possible into the dichloroethane, not just so that there was more R6G to react with 
the aniline later but also so the needle would not be clogged when attempting to transfer the 
dichloroethane into the round bottom. R6G works best under more dilute circumstances, hence 
why the quantities of dichloroethane used in this reaction are far greater than in the RB reaction 
where dilution is not as important. 
 The dissolved R6G-acid was in the round bottom to stir overnight under argon. After 
approximately twenty-four hours, the solution was placed in an ice bath. While still stirring and 
under argon, 3.29 mmol of an aniline derivative was added and left to stir for thirty minutes. 
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After thirty minutes, 0.05 ml of POCl3 (0.54 mmol) was added drop-wise. The formation of 
product upon this addition of POCl3 is almost instantaneous. If the reaction with POCl3 occurs 
too quickly, the R6G-acid will form a byproduct that will precipitate out of the solution so the 
reaction is slowed by use of the ice bath. A suggestion for future synthesis reactions with R6G 
would be the possible use of a dry ice and acetone bath to further slow the reaction, which might 
reduce the number of byproducts. 
 Though I recommended adding POCl3 first in the RB derivative synthesis procedure, I 
feel that given the rapid formation of product it is best added last here. The high reactivity and 
R6G’s tendency to form byproducts would suggest that adding POCl3 first would increase the 
number of byproducts. The ratio of aniline derivative to R6G-acid here is 6.85:1, which is 
appropriate given the already low product yields. In this manner, the synthesis of RB-DNA is 
similar to the synthesis of R6G di-ortho derivatives. The ratio of POCl3 to R6G-acid here is 
1.13:1, which is much closer to the 1:1 ratio I recommended earlier than the ratio used in the RB 
di-ortho synthesis. 
 The mixture was stirred overnight under argon in the ice bath. The next day, the melted 
ice bath was removed and the solution left to stir for another twenty-four hours, with TLC 
confirming the presence of product. The solution was then removed from the stir plate and taken 
off the argon gas before setting up a Buchner filtration. At this stage, anhydrous dicholorethane 
was no longer needed so the filter was washed with non-anhydrous dichloroethane until the 
filtrate was clear. The liquid was then transferred to a large separatory funnel, rinsing the flask 
with more dichloroethane until the liquid in the flask was clear to ensure all possible product was 
retrieved. The work up consisted of four washes with small amounts of chilled base and one 
wash with brine. The organic layer contained product, just as with the RB workup, but particular 
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care was taken with the R6G to be gentle when swirling the separatory funnel. Violent shaking 
encourages emulsion formation while acid protonates the R6G, forming a salt which is difficult 
to dry, hence the lack of an acid wash. Once the solution had been collected from the separatory 
funnel, anhydrous sodium sulfate was used to remove water from the mixture. Once the sodium 
sulfate stopped clumping, another Buchner filtration was performed, including scooping the wet 
sodium sulfate onto the filter and rinsing with chloroform to ensure the greatest transfer of 
product. This solution was then condensed in vacuo before obtaining a 
1
H NMR spectrum to 
determine if the synthesis was successful. 
 The purification process for R6G was basically the same as for RB, discussed in detail 
previously in this paper. Of note though, is that R6G was more prone to getting ‘stuck’ in a 
column due to its reactions with the acidic silica so less silica gel should be used in columns for 
R6G and triethylamine is of particular importance in the solvent. Smaller diameter columns with 
small amounts of silica gel are best for use with R6G compounds. R6G derivative synthesis also 
tends to produce more byproducts so these derivatives typically have to go through more 
columns than the RB series compounds. Additionally, due to the large number of bands, a 
smaller ratio of EtOAc to Hexanes is recommended to promote separation over speed. The heat 
from the rotovap did not appear to have an adverse effect on the R6G derivatives but generally 
the high vacuum line is better for drying the R6G compounds due to the colder environment. 
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C. Conclusions and Future Directions for RSL Synthesis Pathways 
Table 1. Comparison of syntheses for RB and R6G di-ortho substituted derivatives 
 RB di-ortho derivatives R6G di-ortho derivatives 
Number of Steps in Reaction One step Multi-step 
Reaction Time/Condition 
(post aniline and POCl3 
addition) 
Refluxed for 24 hrs Stirred in cold environment 
for 12 hours 
Stirred at room temperature 
for 24 hours 
Atmosphere Open to air Argon atmosphere 
Order of addition of POCl3 
and aniline 
1) POCl3 
2) Aniline 
1) Aniline 
2) POCl3 
Ratio of rhodamine to POCl3 1:2.68 1:1.13 
Ratio of rhodamine to aniline 1:3 1:6.85 
Percent Yield 8-57% 5-18% 
 
While Grace Taumoefolau’s optimized synthesis for R6G derivatives proved efficient, as 
the compounds had relatively high yields for the difficult steric environment, the RB derivative 
synthesis was less efficient. Obviously, the ratio of POCl3 to rhodamine needs to be adjusted 
downwards. The change to an argon atmosphere might be worthwhile in particularly difficult 
syntheses, like the synthesis of RB-DNA; however, overall RB is not as reactive as R6G and so 
maintaining a dry environment would not increase the yield significantly. Certainly the two-step 
procedure seems to be effective at boosting the yield, as it did for RB-DNA; however, I was 
unable to replicate this synthesis after repeated attempts and the RB-acid chloride formed would 
have to be very stable and not particularly likely to react with its environment. A two-step 
procedure creating RB-acid chloride and then adding aniline under argon might be worth 
investigation though. Such a procedure would more closely model the R6G derivative synthesis, 
except with the use of reflux as opposed to an ice bath. Increasing the ratio of rhodamine to 
aniline would help in sterically complex molecules but in a simple RB derivative synthesis it 
would simply be a waste of aniline. These modifications should help in optimizing the synthesis 
procedure for RB di-ortho derivatives and thereby improve the yield.  
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Section II. pKa studies of ortho-substituted RB and R6G derivatives  
A. Titrations of RB and R6G di-ortho compounds 
 Both series of compounds needed to be titrated in order to determine the pKa of each 
compound. Titrations were performed a minimum of four times to determine if the results were 
replicable. The standard deviation of the experimental pKas was used to verify the four titrations- 
if the standard deviation was below 0.1, the titrations were considered accurate and reproducible. 
Compounds were titrated no more than eight times. An overview of the literature reveals that it is 
relatively common to do one titration; however, a minimum of four titrations, with additional 
trials needed if the standard deviation is high, provides greater accuracy.
12,13
 
 The general titration procedure began by massing out approximately 1 mg of the 
compound. This 1 mg (± 0.0003 g) was then dissolved in 25 mL of ethanol (EtOH) in a 
volumetric flask. 10 mL of this solution was then placed in a 100 mL volumetric flask. 40 mL of 
EtOH and 50 mL of de-ionized water (DI H2O) was added to create a 1:1 solution of EtOH to 
water. Since the quantum yield of R6G is greater than for RB, all the R6G compounds and some 
RB compounds had to go through a further dilution, with 10 mL of the 1:1 solution of EtOH 
detailed above placed in a volumetric flask and diluted with another 40 mL of EtOH and 50 mL 
of DI H2O.
15
 RB-DCA and RB-DMA were the only RB compounds which needed to undergo the 
second dilution. These dilutions were stirred for a least 1 hour prior to the titration, which was 
done with 0.1 M HCl acid. The use of acid meant that small quantities of 0.1 M NaOH had to be 
added to the solution before titration in order to raise the pH to a reasonable point where none of 
the compound was in the open form. An example of the fluorescence data obtained from a 
titration is shown in Figure 7. 
 The fluorescence of the compounds as viewed with a fluorimeter increased as the  
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Figure 7. A fluorescence spectra of R6G-DMA throughout the course of a titration. 
 
addition of acid induced a ring opening, transforming the closed and non-fluorescent RSL to the 
fluorescent form. Similarly, the absorbance of the compounds as noted on the UV-Visible  
spectrometer increased with the addition of acid as the compounds changed from the colorless 
forms to the pink ones. However, there was an additional stage at which both the fluorescence 
and absorbance stopped increasing and in fact began to decrease. This loss of fluorescence 
demonstrates the transformation of the fluorescent form of the dye into a second colorless and 
non-fluorescent form
13
. At what pH the ring started opening and when the fluorescence reached 
its peak was dependent upon the compound. R6G compounds had a λmax,fl in the 551-555 nm 
range while RB compounds had their peaks from 581-583 nm, depending on the attached 
substituent. 
The peak fluorescence intensity of the compounds was graphed against the pH to develop 
a titration curve, as shown in Figure 8. In this particular graph, the maximum fluorescent 
intensity was 495 at 552 nm and the fluorescence intensities were normalized so that 495 was 1.0 
on the fluorescent intensity axis in the figure. The midpoint of the titration curve, that is the pH 
at which the fluorescence intensity is 0.5 on the normalized graph, is the pKa of the compound. A  
pH= 10.42 
pH= 3.59 
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Figure 8. Graph of fluorescence peak intensity versus pH for R6G-DMA. 
Table 2. Average pKa values for the RB and R6G di-ortho series. 
Substituent RB pKa R6G pKa 
H 4.31 ± 0.02 3.81 ± 0.02 
F 4.52 ± 0.08 4.30 ± 0.04 
Cl 5.38 ± 0.08 5.62 ± 0.04 
OEt 4.03 ± 0.07 4.15 ± 0.05 
Me 4.90 ± 0.11 5.32 ± 0.07 
iPr 5.72 ± 0.13 5.87 ± 0.06 
 
more exact method of determining the pKa was through the use of a modified Henderson-
Hasselbalch equation to account for the two colorless and non-fluorescent forms of the RSL, as 
mentioned in the introduction.
13
 For the R6G-DMA titration from Figure 8, the pKa was 5.33. 
R6G typically fluoresces at a higher pKa than RB. This general trend is observed in most 
of the collected data, with the exceptions being R6G-A and R6G-DFA. As a result, R6G covered 
the greatest pH range for a total range of 2.06 as compared to RB’s range of 1.69. Given that the 
substituents H and F have the smallest steric bulk, these observations can be interpreted as being 
due to steric interactions. R6G compounds tend to have higher pKas because their additional 
methyl group on the xanthene ring creates greater steric strain, which makes the spirolactam ring 
more likely to open. It appears that this steric interaction only drives the opening of the 
spirolactam ring when the di-ortho substituents on the attached aniline ring have a greater steric 
bulk. This explanation does not explain why the pKa for these compounds is lower than the RB 
pKa= 5.36 
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versions. One possible explanation is that conformationally flexible nature of the ethyl groups off 
of the xanthene ring nitrogens in RB compounds results in an ethyl group flipping back to 
interact with the RB substituents. 
Yuan and colleagues hypothesized that steric effects were what determined the pKa of a 
compound and that larger groups would increase the pKa.
12
 Their findings were supported by 
Czaplyski’s own RB para-substituted derivatives, which had a narrow range of pKa values. The 
narrow range indicated that electronics did not play a role in the spirolactam ring opening.
13
 We 
did find that bulkier substituents tended to increase the pKa as in the case of RB-DCNA (pKa of 
5.46) and both the RB and R6G di-ortho isopropyl aniline substituted derivatives. However, the 
narrow range mentioned for the para-substituted compounds (4.14 ± 0.04) cannot be entirely 
trusted as repeated titrations on RB-A and RB-4Cl resulted in values of 4.31 and 4.21 
respectively.
13
 Both are increases from their previously reported values. We can assume that the 
remainder of the compounds still remain within a relatively narrow distribution of pKa values, 
albeit slightly higher ones than originally thought; however, there is some evidence contradicting 
this assumption. 
As mentioned in the introduction, Yuan’s R6G-4OH had a pKa value of 3.2.
12
 If the pKa 
for the RB version of this derivative is less than the R6G-4OH, as RB compounds tend to be 
lower in pKa than their R6G counterparts, the para-substituent is significantly different from the 
narrow range suggested by Czaplyski’s results. The hydroxyl group is strongly electron donating 
when attached to an aromatic system, more so than the -OCH3 para-substituent in Czaplyski’s 
paper.
13
 Otherwise, it does not have a greater steric bulk than the other para-substituted RB 
derivatives Czaplyski tested. Thus, if the pKa is lower, it is due to electronic effects. 
The protonated intermediate form of the rhodamine has a positive charge(see Scheme 1).  
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Table 3. Average pKa values for the additional titrations. RB-2,6 DCPA is RB-2,6-(C5H4)2, RB-
3,5-DCA is RB-3,5-Cl2, RB-4CA is RB-4-Cl, and RB-DCNA is RB-2,6-Cl2-4-NO2. 
Compound pKa 
RB-2,6DCPA 4.97 ± 0.06 
RB-3,5DCA 4.34 ± 0.05 
RB-4CA 4.21 ± 0.01 
RB-DCNA 5.46 ± 0.03 
 
This charge can be stabilized by electron donating groups so that the intermediate is more 
favorable. Only when the steric bulk is great enough can it overcome this stabilizing effect, as 
seen with both RB-DIA and R6G-DIA. In comparison, the electron withdrawing groups 
destabilize the intermediate, making it less favorable and thereby raising the pKa of the 
derivative. Since –OH is electron donating, it is possible that the para-substituent can still 
stabilize the intermediate, which could explain the possibly lower pKa. 
Steric effects did not appear to influence the ring opening in the case of the para-
substituents. The pKa value does not increase significantly as the steric bulk of the substituent 
increases. Presumably, the para-substituents are located far enough away from the spirolactam 
ring that both their steric and electronic properties do not play nearly as great a role as they do in 
the ortho-substituted derivatives. 
Returning to the R6G-4OH, it is quite possible that this R6G compound has a lower pKa 
than its hypothetical RB counterpart. Remember that R6G-A and R6G-DFA had smaller pKas as 
compared to RB-A and RB-DFA. While –OH has a larger steric bulk than both of these 
substituents, the fact that the substituents are di-ortho doubles their steric bulk so that –OH is 
closer in size to them. Additionally, it is possible that it is removed enough from the spirolactam 
ring that it effects the ring system as would a smaller substituent, in that the R6G versions have a 
smaller pKa than the RB ones. This latter explanation for the inconsistent pKa is one I found 
more believable than the idea that RB-4OH would have a pKa of less than 3.2 when we know 
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that the para-substituted compounds generally have a small range of pKa values. To be fully 
confident that para-substituted derivatives are not impacted by electronic effects, the compounds 
would need to be tested again. Until that time, we will assume that, given the distance of the 
para-substituents from the spirolactam ring, our original deduction that the electronics do not 
play much of a role in their pKa values is accurate. 
 The di-meta RB chloroaniline (see Table 3) had a pKa much lower than the di-ortho 
substitution which suggests that, like the para position, substituents on the meta position are not 
in a position of steric strain such that the pKa would be increased. The fact that the pKas for the 
para and di-meta chloroanilines are very similar supports this hypothesis. The di-meta position 
was slightly higher than the para, which makes sense as the double substitution on the slightly 
closer positions would make the spirolactam ring slightly more strained. Unfortunately, we 
cannot tell what the role of electronics in this particular ring opening is based off of these 
titrations alone. 
 Titrations were attempted on RB-DCPA. However, the compound did not dissolve well 
in the titration solvent of ethanol and de-ionized water. Since RB-DCPA was not visible on the 
UV-Vis, the titration values obtained cannot be considered completely accurate results. 
However, the higher pKa for the compound is as expected for a slightly more bulky substituent. 
RB-DNA was also titrated, but it would only close when dissolved in pure triethylamine, a range 
above which our pH probe covered. While clearly possessing a pKa in the more basic region and 
therefore not suited for our purposes of developing a pH probe for the acidic region, this does 
provide some interesting information regarding the role of sterics and electronics. –NO2 is not 
very sterically bulky but it is extremely electron withdrawing. We can already see from the trend 
of the other electron withdrawing groups (-H, -F, -Cl) that the pKa rises with increasing steric 
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bulk. NO2 does have a higher A value than the other electron withdrawing groups tested here. 
The most electron donating group (-OEt) has a lower pKa than the least electron donating (-iPr). 
For the RB series, -OEt has a lower pKa than the least electron withdrawing substituent (-H). As 
explained above, electron donating groups can stabilize the protonated intermediate which would 
explain their comparatively lower pKa values. Thus it appears that the more electron 
withdrawing and bulky a substituent is, the higher the pKa. However, as I mentioned before, at 
some point we exit the acidic region we want to study so increasing the pKa as far as it will go 
was not the purpose of this research. 
Czaplyski’s study of the para-substituted RB derivatives also demonstrated that electron 
withdrawing substituents had the highest intensity of fluorescence.
13
 These findings were not 
supported by my experiments. Both RB-DCA and RB-DMA had to be diluted a second time 
because their fluorescence intensity was too great for the instrument at their peak intensity. R6G-
DMA was also comparably bright versus the R6G derivatives with electron withdrawing 
substituents.  
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B. Titrations of RB mono-ortho compounds 
Table 4. Average pKa values for the RB mono-ortho series. 
Substituent RB pKa 
F 4.33 ± 0.01 
Cl 4.43 ± 0.08 
Me 4.31 ± 0.02 
iPr 4.28 ± 0.02 
 
 In order to determine the role of mono versus di substitutions on ring opening, Mona 
Rasooly and I performed titrations on several RB mono-ortho versions of the di-ortho series 
discussed previously. Though the majority of this paper involves modeling and discussions of the 
di-ortho series, these results are useful as an additional piece of evidence proving that di-ortho 
substitutions place the spirolactam ring under greater stress, causing it to open at higher pKa 
values than mono-ortho substitutions. The goal was a minimum of four titrations, done using the 
same procedure mentioned previously. However, at the time this paper was written only RB-
2MA had four complete titrations with all the others having three trials. None of these 
compounds needed an additional dilution from the original one. 
 The mono-ortho compounds had lower pKa values than their di-ortho counterparts. Since 
the mono-ortho variations can rotate so as to reduce the strain generated by the substituent, the 
ring was not popped open as easily. Like the para-substituted compounds, the mono-ortho 
compounds were in a relatively narrow range of values close to the pKa of RB-A (4.31). The 
modeling of this data will be discussed in the next section, in addition to the modeling of the di-
ortho derivatives. However, it is already clear that sterics effects are not as present in these 
compounds as electronic. The mono-iPr compound has a lower pKa in comparison to the RB-
2CA, which suggests that the pKa in the mono-ortho derivatives is primarily determined by 
electronic effects.  
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C. Mathematical prediction of R6G and RB di-ortho pKa 
 There are multiple means of measuring sterics and electronics mathematically in a 
system. Steric parameters include A values, Taft Es, Charton’s υ, Meyer’s V
a
 values, and I
X-H
 
(kJ/mol). A values are a numerical measurement of the preference for an equatorial as opposed to 
axial oriented substituent in a mono-substituted cyclohexane.
20
 The steric substituent Es is taken 
from the Taft equation, a measure of rates
20
: 
             
             (4) 
Given this equation, when polar effects are not present (σ*), we can thereby reduce the equation 
to
21
: 
   
 
  
         (5) 
Thus, Taft defined Es as a steric parameter, however it could also include effects that do not 
originate from the polar effect, the combination of field and resonance effects, given by σ*. 
Research has shown that Es is impacted by solvent effects.
21
 Kutter and Hansch derived a 
variation of these Es values, improving upon Taft’s work and correcting the scale.
22
 While these 
Es values, at least for groups fitting the formula of CH2X, CHX2, and CX3, correlate with the van 
der Waals radii, Charton’s υ values are entirely derived from the van der Waals radii. As such, 
they are based solely on the size of the substituent. Meyer’s Va values are a measurement of the 
volume of the substituent within a designated distance of 0.3 nm from the reaction site.
21
 I
X-H
 
was derived from the free energies of activation.
23
 
The values used as electronic parameters included the Hammett sigma constant σpara, σI, 
Traynham’s σo, and Swain-Lupton-Hansch’s F and R. Electronic parameters can consist of a 
combination of an inductive effect, resonance effect, and field effect.
24
 While the Hammett 
equation is commonly used to model these interactions, it is typically applied to cases where 
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meta- or para-substituents impact the reactivity of a functional group in a benzene derivative so 
Hammett constants only account for the electronics of the meta and para substitutions (σmeta and 
σpara respectively).
20
 
   
 
  
         (6) 
However, several papers have studied the applicability of these constants to ortho-substituents 
and found that the σpara, or σp, can be used to model these series.
25,26
 Since σp was defined based 
on whether the substituents increased the acidity of benzoic acid or not, electron withdrawing 
groups have a positive σp while electron donating groups have a negative σp.
20
 The σI was once 
again determined by Taft as a measure of the field effect, which was not included in the Taft 
equation listed above. If field effects are measured independently than resonance effects must be 
as well
21
. 
   
 
  
                (7) 
Traynham’s σo constant was developed as an improvement upon Taft’s σo*, which only 
included polar effects. In comparison, Traynham’s constant was based off of chemical shifts. The 
reliability of this measurement was based off of good correlation with the para-substituted 
phenols tested and reactivity data. This constant is not necessarily independent of sterics 
though.
21
 
Swain and Lupton developed F, field effect, and R, resonance, constants. As demonstrated in 
the below equation, F and R split σ into two different contributions, just like the σI and σR.
21
 
             (8) 
The F values determined by Swain and Lupton were later modified by Hansch to improve the 
scale. These values for field effect were combined with Taft-Kutter-Hansch’s steric parameter, 
Es, and the Hammett constant, σp, to form the Fujita-Nishioka equation. This equation serves as a 
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model for ortho compounds in circumstances where proximity polar and steric effects are 
independent of polar effects. 
                       (9) 
However, Fujita and Nishioka recognized that σp was not the greatest estimate for ortho 
compounds, as resonance and inductive effects differ between para and ortho substituents.
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Additionally, this equation, like others mentioned previously, is based on kinetics, whereas we 
are looking to model pKa. Therefore, a variety of parameters were tested. 
When modeling the pKa data by the steric and electronic effect, we multiplied the 
constants by two to account for the di-ortho substitution.
26,27
  However, since all the data in this 
set are di-ortho, this change doesn’t particularly matter in the regressions themselves as the 
coefficients would adjust the intensity of the effect as needed. The parameters for the steric and 
Table 5. Steric parameters for modeling di-ortho series  
Substituent A
1
 Es
2
 υ
3
 V
a3 
I
X-H
 kJ/mol
4
 
H 0.00 0.00 0.00 0.00 8.00 
F 0.30 -0.92 0.54 2.44 38.4 
Cl 0.86 -1.94 1.10 5.08 76.2 
OEt 1.80 -1.10 0.96
5
 6.78* 53.2* 
Me 3.40 -2.48 1.04 5.68 80.8 
iPr 4.30 -3.42 1.52 11.48 105.2 
 
                                                             
1
 http://chem.wisc.edu/areas/organic/index-chem.htm 
2
 Fujita, T. and Nishioka, T. The Analysis of the Ortho Effect. Prog. Phys. Org. Chem. 1976, 12, 49-89. 
3
 Smith, M. B. and March, J. March’s Advanced Organic Chemistry: Reactions, Mechanisms, and Structure. John 
Wiley & Sons. 2007. 
*No value for OEt so substituted in OMe 
4
 Bott, G.; Field, L. D.; and Sternhell, S. Steric Effects. A Study of a Rationally Designed System. J. Am. Chem. Soc. 
1980, 102, 5618-5626. 
5
 http://www.wiredchemist.com/data/hammett-sigma-constants 
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Table 6. Electronic parameters for modeling di-ortho series 
 
Substituent σp
2 σo
6
 F
2 
R
2 σI
2 σI
mod7
 
H 0.00 0.00 0.00 0.00 0.00 0.00 
F 0.12 0.58 0.86 -0.68 1.04 1.04 
Cl 0.46 1.00 0.82 -0.30 0.94 0.94 
OEt -0.48 -0.60 0.44 -0.88 0.54 0.54 
Me -0.34 -0.26 -0.08 -0.26 -0.10 0.00 
iPr -0.30 -0.30 -0.10 -0.20 -0.12 0.00 
 
electronic models are given in Tables 5 and 6 respectively. 
First, I graphed the pKa data against both steric and electronic measures. All these graphs  
can be found in Appendix C but I will discuss some significant ones in depth here. When the 
pKa data was graphed versus the A values, there was notable distinction between the electron 
withdrawing substituents and the electron donating ones, a trait that is also present in the pKa  
versus σp graph (see Figures 9, 10, and 11). This trend implied that A values were not simply a 
steric measure but possibly had an electronic component. Since A values are measures of the 
preference for an equatorial as opposed to axial oriented substituent it makes since that 
electronics properties of substituents could play some role in this preference.
20
 A regression 
testing the collinearity, that is how much the independent variables are related to each other, 
between A values and σp resulted in a variance inflation factor (VIF) of 1.729 for RB derivatives 
and 1.790 in R6G ones. These values are not exceedingly large but they do indicate there is some 
                                                             
6
 Tribble, M. T. and Traynham, J. G. Nuclear Magnetic Resonance Studies of ortho-Substituted Phenols in Dimethyl 
Sulfoxide Solutions. Electronic Effects of ortho-Substituents. Journal of the American Chemical Society. 1969, 
91(1), 379-388. 
7
 Bijloo, G. J. and Rekker, R. F. Some Critical Remarks Concerning the Inductive Parameter σI Part IV: 
Parametrization of the Ortho Effect in Anilines and Pyridines. Quant. Struct. Act. Relat. 1984, 3, 111-115. 
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relationship between A values and σp. They were also higher than the VIF factors for σp and Es 
(1.085 for R6G and 1.081 for RB). 
 
Figure 9. RB and R6G pKa data for di-ortho substituents versus their A values 
 
 
Figure 10. RB and R6G pKa data for electron withdrawing di-ortho substituents versus their A 
values 
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Figure 11. RB and R6G pKa data for electron donating di-ortho substituents versus their A 
values 
 
In comparison, the graphs of pKa versus Es and I
X-H
 were much more linear in 
appearance, suggesting that those models are a better measure of solely steric parameters as 
opposed to electronic. The Meyer’s Va graph also showed some linearity, broken by the data 
points for RB-DEA and R6G-DEA. This discrepancy might be a result of the substitution of the 
V
a
 of –OMe for –OEt. 
 Among the electronic parameters versus pKa graphs, σp showed the best linearity within 
electronic withdrawing and donating groups. While σo, F, and σI were also split into different 
groups based on whether they were electron withdrawing or electron donating, their linearity 
within those categories was not as good, which led me to believe that σp was in fact the best 
model for the ortho substituents. However, R versus the pKa showed good linearity without any 
distinction between electron withdrawing or donating. The Fujita-Nishioka assumes that there is 
no proximity resonance effect and while the changes in pKa for R are not massive, it does appear 
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that the resonance has a distinct effect. This effect could mean that the Fujita-Nishioka equation 
might have to be modified to include an R parameter.
22
 
                         (10) 
The RB and R6G derivatives could not be modeled together as the coefficients are too 
different across the derivatives. Such variation is likely due to the different interactions created 
by the methyl group in R6G. Table 7 contains the R6G regressions, while Table 10 contains the 
RB regressions. Based on the trend for the A values graphed versus the pKa a regression was run 
on solely on A and Es values to see what, if any trend, they demonstrated. Once again, in both 
RB and R6G, the A values seemed to have a notable electronic effect, as evidenced by the two 
distinct lines (top is electron donating while bottom is electron withdrawing) corresponding to 
the electron withdrawing and donating substituents (Figure 12). In comparison, Es appeared to 
be a much better model of sterics given the linear shape (Figure 13). The fact that the points are 
already mostly linear implies a strong reliance on sterics with electronic parameters required 
solely to fit the line better.  Additionally, the A-σp regression has clear patterns in the residuals, 
which implies that there is another variable needed to explain the pKa trends. 
 
Figure 12. R6G A value predicted pKa versus experimental pKa 
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Table 7.  R6G regression analysis 
 A-σp Es- σp υ- σp I
X-H
- σp V
a
- σp A-σo 
Intercept 
P-value 
3.893 (± 0.028) 
2.43e-54 
3.736 (± 0.034) 
4.72e-50 
3.637 (± 0.088) 
9.05e-34 
3.453 (± 0.0515) 
6.53e-42 
3.866 (± 0.101) 
1.56e-32 
3.713 (± 0.049) 
5.64e-44 
Steric 
P-value 
0.647 (± 0.014) 
2.43e-54 
-0.723 (± 0.018) 
2.59e-33 
1.530 (± 0.094) 
5.7e-19 
0.024 (± 0.001) 
2.76e-29 
0.218 (± 0.018) 
8.57e-15 
0.584 (± 0.021) 
1.95e-27 
Electronic 
P-value 
2.337 (± 0.074) 
2.99e-35 
0.853 (± 0.064) 
4.55e-16 
0.643 (± 0.147) 
8.73e-05 
0.658 (± 0.080) 
4.64e-10 
1.166 (± 0.202) 
1.1e-06 
1.215 (± 0.062) 
8.53e-22 
Field/Other 
P-value 
      
Other 
P-value 
      
Adjusted R
2
 0.980 0.975 0.865 0.960 0.780 0.951 
df 41 41 41 41 41 41 
n 42 42 42 42 42 42 
F 
P-value 
1018.1 
2.2e-34 
805.937 
1.91e-32 
132.688 
3.96e-18 
493.763 
2.01e-28 
73.655 
5.7e-14 
399.504 
1.05e-26 
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R6G Es-σo υ- σo I
X-H
- σo V
a
- σo A-F Es-F 
Intercept 
P-value 
3.679 (± 0.046) 
7.25e-45 
3.602 (± 0.094) 
1.54e-32 
3.420 (± 0.061) 
7.13e-39 
3.758 (± 0.106) 
2.87e-31 
3.714 (± 0.161) 
2.51e-24 
3.646 (± 0.085) 
2.04e-34 
Steric 
P-value 
-0.694 (± 0.023) 
8.71e-29 
1.479 (± 0.097) 
4.54e-18 
0.024 (± 0.001) 
1.58e-26 
0.209 (± 0.017) 
7.08e-15 
0.498 (± 0.055) 
4.83e-11 
-0.688 (± 0.037) 
6.31e-21 
Electronic 
P-value 
0.445 (± 0.047) 
1.21e-11 
0.329 (± 0.088) 
0.000561 
0.333 (± 0.053) 
2.18e-07 
0.662 (± 0.112) 
6.65e-07 
0.980 (± 0.210) 
3.5e-05 
0.327 (± 0.098) 
0.0018 
Field/Other 
P-value 
      
Other 
P-value 
      
R
2
 Adjusted 0.958 0.853 0.946 0.785 0.660 0.893 
df 41 41 41 41 41 41 
n 42 42 42 42 42 42 
F 
P-value 
471.852 
4.72e-28 
119.501 
2.33e-17 
356.973 
8.49e-26 
76.021 
3.5e-14 
40.723 
2.82e-10 
172.639 
4.22e-20 
41 
 
R6G υ-F I
X-H
-F V
a
-F A-R ES-R υ-R 
Intercept 
P-value 
3.706 (± 0.117) 
1.73e-29 
3.459 (± 0.093) 
4.87e-32 
3.915 (± 0.157) 
1.5e-25 
4.405 (± 0.176) 
1.21e-25 
3.934 (± 0.095) 
7.72e-34 
3.941 (± 0.078) 
4.27e-37 
Steric 
P-value 
1.440 (± 0.112) 
1.33e-15 
0.023 (± 0.001) 
5.8e-21 
0.181 (± 0.023) 
7.87e-10 
0.339 (± 0.055) 
3.56e-07 
-0.6509 (± 0.039) 
1.53e-19 
1.533 (± 0.074) 
1.27e-22 
Electronic 
P-value 
-0.066 (± 0.129) 
0.612 
0.102 (± 0.095) 
0.291 
0.232 (± 0.187) 
0.222 
0.292 (± 0.322) 
0.370 
0.340 (± 0.156) 
0.035 
0.957 (± 0.131) 
8.92e-09 
Field/Other 
P-value 
      
Other 
P-value 
      
R
2
 Adjusted 0.800 0.894 0.608 0.480 0.878 0.915 
df 41 41 41 41 41 41 
n 42 42 42 42 42 42 
F 
P-value 
83.240 
8.45e-15 
173.467 
3.88e-20 
32.784 
4.44e-09 
19.924 
1.09e-06 
147.951 
6.16e-19 
221.172 
5.22e-22 
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R6G I
X-H
-R V
a
-R A-σI Es- σI υ- σI I
X-H
- σI 
Intercept 
P-value 
3.700 (± 0.075) 
9.79e-37 
4.259 (± 0.143) 
2.05e-28 
3.744 (± 0.166) 
5.81e-24 
3.654 (± 0.087) 
4.39e-34 
3.714 (± 0.117) 
1.64e-29 
3.465 (± 0.094) 
6.46e-32 
Steric 
P-value 
0.0233 (± 0.001) 
5.88e-25 
0.181 (± 0.020) 
5.12e-11 
0.491 (± 0.057) 
1.64e-10 
-0.688 (± 0.038) 
1.32e-20 
1.438 (± 0.112) 
1.3e-15 
0.023 (± 0.001) 
7.42e-21 
Electronic 
P-value 
0.586 (± 0.113) 
6.86e-06 
0.763 (± 0.258) 
0.0052 
0.784 (± 0.183) 
0.000114 
0.260 (± 0.084) 
0.00366 
-0.0738 (± 0.109) 
0.502 
0.072 (± 0.081) 
0.376 
Field/Other 
P-value 
      
Other 
P-value 
      
R
2
 Adjusted 0.935 0.667 0.639 0.890 0.801 0.893 
df 41 41 41 41 41 41 
n 42 42 42 42 42 42 
F 
P-value 
297.428 
2.44e-24 
42.097 
1.82e-10 
37.317 
8.78e-10 
166.276 
8.14e-20 
83.758 
7.66e-15 
171.800 
4.59e-20 
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R6G V
a
-σI Es-σp-F-R Es-σp-F Es-σp-R Es-F-R Es-σI-R 
Intercept 
P-value 
3.931 (± 0.158) 
1.69e-25 
3.831 (± 0.026) 
8.68e-53 
3.822 (± 0.038) 
1.03e-47 
3.822 (± 0.038) 
9.39e-48 
3.822 (± 0.038) 
6.58e-48 
3.824 (± 0.040) 
4.68e-47 
Steric 
P-value 
0.181 (± 0.023) 
1.06e-09 
-0.640 (± 0.016) 
3.84e-32 
-0.7179 (± 0.016) 
9.08e-35 
-0.718 (± 0.016) 
8.62e-35 
-0.716 (± 0.016) 
6.1e-35 
-0.721 (± 0.017) 
4.34e-34 
Electronic 
P-value 
0.167 (± 1.59) 
0.300 
-47.231 (± 7.280) 
1.38e-07 
1.052 (± 0.078) 
4.17e-016 
0.828 (± 0.056) 
2.74e-17 
0.775 (± 0.052) 
1.92e-17 
0.665 (± 0.048) 
1.42e-16 
Field/Other 
P-value 
 44.941 (± 6.808) 
9.68e-08 
-0.209 (±0.057) 
0.00075 
0.227 (± 0.061) 
0.000677 
1.062 (± 0.077) 
2.65e-16 
1.097 (± 0.083) 
1.03e-15 
Other 
P-value 
 48.657 (± 7.336) 
8.8e-08 
    
R
2
 Adjusted 0.604 0.991 0.981 0.981 0.982 0.980 
df 41 41 41 41 41 41 
n 42 42 42 42 42 42 
F 
P-value 
32.217 
5.49e-09 
1150.979 
2.93e-38 
713.172 
1.96e-33 
716.851 
1.78e-33 
730.585 
1.25e-33 
656.677 
9.11e-33 
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R6G Es-σI-F Es-σI-F-R Es-σI
mod
-F-R    
Intercept 
P-value 
3.791 (± 0.024) 
6.42e-55 
3.816 (± 0.017) 
9.94e-60 
3.828 (± 0.024) 
2.47e-54 
   
Steric 
P-value 
-0.600 (± 0.011) 
1.11e-37 
-0.639 (± 0.009) 
1.87e-40 
-0.814 (± 0.016) 
8.09e-36 
   
Electronic 
P-value 
-14.673 (± 0.672) 
4.22e-23 
-10.065 (± 0.816) 
1.14e-14 
-4.083 (± 0.532) 
3.66e-09 
   
Field/Other 
P-value 
17.642 (± 0.794) 
2.22e-23 
12.384 (± 0.942) 
1.62e-15 
5.191 (± 0.576) 
7.34e-11 
   
Other 
P-value 
 0.4236 (± 0.062) 
5.36e-08 
0.720 (± 0.066) 
4.29e-13 
   
R
2
 Adjusted 0.992 0.996 0.993    
df 41 41 41    
n 42 42 42    
F 
P-value 
1676.98 
2.09e-40 
2763.502 
2.94e-45 
1397.373 
8.31e-40 
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Figure 13. R6G Es predicted pKa versus experimental pKa 
 
 
 As expected the Fujita-Nishioka equation produced good correlation (adjusted R
2
 of 
0.981 and 0.950 for R6G and RB respectively). However, the modified version of the equation 
with the addition of the resonance factor, R, produced even better correlations for R6G. It 
appears that σpara does not fully account for the field and resonance effects in di-ortho substituted 
compounds, at least in R6G. Since RB had such large p-values for the modified Fujita-Nishioka 
equation it would seem that σpara does account more for these effects. For the regressions with σI, 
RB seemed to be much more dependent upon resonance than R6G derivatives, which had best 
results with resonance and field effects added to the regression. As suggested by Bijloo and 
colleagues, the substitution of σI for σp resulted in stronger correlations but the change was not 
especially large. The modified σI did not produce better results, which suggests the spirolactam 
ring significantly changes the properties of the compound from just the plain anilines Bijloo 
examined.
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 To summarize, for the R6G derivatives, the best three parameter correlation was with Es-
σI-F (Figure 14). 
                                                                   
The electronic parameters are surprisingly the most weighted, even with R6G’s added steric 
strain. In other words, the percent weight of each parameter is 4.309, 47.495, and 48.196 for Es, 
σI, and F respectively. These weights are calculated as the percent contribution from each 
coefficient after standardizing the parameters, in other words by taking the beta. The beta is 
given at the value of the parameter minus the mean all divided by the standard deviation. Once a 
regression is run on these new standardized values you can take one coefficient for a parameter 
and divide it by the total sum of the coefficients for your parameters. This process tells you 
approximately how much the coefficients contribute; if your coefficient for the steric parameter 
is comparatively large then it is weighted more in the regression. As expected, the parameters 
were correlated with each other, particularly σI and F with a VIF of 811.429. This is an 
extremely high correlation which could contribute to inaccurate parameter estimates and could 
explain the oddly high reliance on electronics. This correlation was also present with the 
modified σI values.  If we return to the Fujita-Nishioka equation parameters, we find that σp is 
much less correlated with F (VIF of 2.057) (Figure 15). 
                                                                 
This equation generates a much more believable weighting for the electronic and steric 
parameters; F contributes 7.282%, σp contributes 27.030%, and Es contributes 65.689%. Given 
the steric strain in the R6G compounds, I find this equation more trustworthy. Therefore, even 
though σI has the greatest fit, I find that σp is more accurate in describing the effects of the 
electronic and steric parameters. 
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Figure 14. R6G Es–σI-F regression predicted pKa versus pKa of di-ortho derivatives 
 
 
Figure 15. RB Es-σp-F regression predicted pKa versus pKa of di-ortho derivatives 
 
Table 8. Analysis of VIFs of R6G three-parameter regression models 
 
R6G Es-σI-R Es-σp-R Es-F-R 
Es-R 1.004 1.004 1.004 
Es-σI/ σp/F 1.079 1.085 1.072 
R-σI/ σp/F 1.691 1.011 1.624 
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As shown in the table above (Table 8), even though Es- σI-R and Es-F-R have the better 
fits of the values predicted by the regression with the actual data points, the VIF of R-σI and R-F 
is significantly larger than R-σp. Therefore, for a three parameter model, a modified version of 
the Fujita-Nishioka is best, substituting R for F (Figure 16). 
                                                                 
R has less correlation with σp than F (VIF of 1.01 versus 2.06) as well as slightly less correlation 
with Es (VIF of 1.00 versus 1.07). Though the electronic values do show some correlation with 
Es the effects are not significant enough to interfere with the coefficient values. The weightings 
in this equation are 23.104%, 71.309%, and 5.567% contribution from σp, Es, and R respectively. 
 
Figure 16. R6G Es–σp-R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure 17. R6G Es–σp-F-R regression predicted pKa versus pKa of di-ortho derivatives 
 
Given what we now know about σI correlation with F, the best four parameter model 
would be based on the Fujita-Nishioka equation (Figure 17). 
                                                                  
                 
However, the weighting for the steric and electronic components are drastically changed by the 
addition of another electronic parameter. The steric parameter now contributes 1.488% to the 
pKa which cannot be accurate given the steric strain present in R6G. Therefore we must conclude 
that four parameters are not accurate for the estimation of the contributions of steric and 
electronic effects, most likely due to the addition of correlations between the independent 
variables. 
 The parameters for the R6G regressions with adjusted R
2
 values of 0.9 or greater were 
used as the parameters for the RB regressions. Overall, RB derivative were less mathematically 
sound. That is to say that they did not fit the mathematical model as well as the R6G derivatives. 
It was also evident from the regressions that there were significant differences in the steric and 
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electronic contributions. With Es-σp-R, Es-F-R, Es-σp-F, and Es-σI-R having the best fits in the 
regression analysis, their VIF values were compared to determine which would be the best 
model. As shown in Table 9 below, the significant differences in VIF came from the 2
nd
 and 3
rd
 
terms. σp-R had less correlation than σp-F, which was expected given the high p-values for σI-F. 
The greater correlation with F was also found in the R6G model, so σp most accurately 
represents the field effects of ortho-substitution in our rhodamine models. Once again, σp-R also 
had less correlation than σI-R so as was the case with the R6G derivatives, Es-σp-R is the best 
model (Figure 18). 
Table 9. Analysis of VIFs of RB three-parameter regression models 
RB Es-σp-R Es-σp-F Es-F-R Es-σI-R 
1
st
-2
nd
 Term 1.081 1.081 1.108 1.095 
1
st
-3
rd
 Term 1.016 1.108 1.016 1.016 
2
nd
-3
rd
 Term 1.032 1.861 1.566 1.637 
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Table 10 RB regression analysis 
 A-σp Es-σp I
X-H
- σp A-σo Es-σo I
X-H
- σo 
Intercept 
P-value 
4.184 (± 
0.036) 
1.65e-55 
4.077 (± 
0.050) 
9.84e-49 
3.901 (± 
0.082) 
8.26e-39 
4.049 (± 
0.062) 
1.38e-44 
4.018 (± 
0.063) 
2.67e-44 
3.862 (± 
0.092) 
1.75e-36 
Steric 
P-value 
0.449 (± 
0.018) 
2.93e-27 
-0.499 (± 
0.026) 
6.9e-23 
0.016 (± 
0.001) 
4.83e-17 
0.395 (± 
0.026) 
1.03e-18 
-0.470 (± 
0.031) 
4.84 e-19 
0.016 (± 
0.001) 
5.55e-15 
Electronic 
P-value 
1.883 (± 
0.092) 
1.01e-23 
0.871 (± 
0.092) 
4.84e-12 
0.757 (± 
2.72e-07) 
2.72e-07 
0.941 (± 
0.078) 
2.65e-15 
0.432 (± 
0.064) 
2.73e-08 
0.370 (± 
0.078) 
2.55e-05 
Field/Other 
P-value 
      
Other 
P-value 
      
Adjusted 
R
2
 
0.936 0.897 0.808 0.842 0.847 0.765 
df 45 45 45 45 45 45 
n 46 46 46 46 46 46 
F 
P-value 
327.856 
9.27e-27 
197.449 
2.14e-22 
95.848 
1.42e-16 
120.791 
2.26e-18 
125.847 
1.07e-18 
74.120 
1.16e-14 
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RB υ-R I
X-H
-R Es-σp-F-R Es-σp-F Es-σp-R Es-F-R 
Intercept 
P-value 
4.414 (± 
0.086) 
3.9e-40 
4.260 (± 
0.094) 
5.75e-38 
4.282 (± 
0.047) 
5.69e-49 
4.282 (± 
0.046) 
3.71e-50 
4.282 (± 
0.046) 
3.76e-50 
4.283 (± 
0.046) 
3.79e-50 
Steric 
P-value 
0.967 (± 
0.078) 
1.06e-15 
0.015 (± 
0.001) 
5.36e-16 
-0.479 (± 
0.026) 
2.47e-21 
-0.476 (± 
0.018) 
1.43e-27 
-0.476 (± 
0.018) 
1.59e-27 
-0.475 (± 
0.018) 
1.66e-27 
Electronic 
P-value 
1.089 (± 
0.134) 
2.97e-10 
0.832 (± 
0.130) 
1.02e-07 
2.690 (± 
12.296) 
0.828 
1.246 (± 
0.085) 
3.98e-18 
0.771 (± 
0.066) 
9.4e-15 
0.721 (± 
0.062) 
9.52e-15 
Field/Other 
P-value 
  -1.796 (± 
11.504) 
0.876 
-0.444 (± 
0.065) 
2.96e-08 
0.479 (± 
0.071) 
2.98e-08 
1.257 (± 
0.086) 
4.05e-18 
Other 
P-value 
  -1.458 (± 
12.406) 
0.907 
   
Adjusted 
R
2
 
0.811 0.817 0.949 0.950 0.950 0.950 
df 45 45 45 45 45 45 
n 46 46 46 46 46 46 
F 
P-value 
97.38.384 
1.08e-16 
101.1789 
5.48e-17 
208.568 
1.15e-26 
284.772 
6.28e-28 
284.696 
6.31e-28 
284.525 
6.39e-28 
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RB Es-σI-R Es-σI-F-R Es-σI-F Es-σI
mod
-F-R   
Intercept 
P-value 
4.283 (± 
0.044) 
4.58e-51 
4.297 (± 
0.038) 
1.32e-52 
4.075 (± 
0.100) 
2.59e-35 
4.281 (± 
0.047) 
4.32e-49 
  
Steric 
P-value 
-0.471 (± 
0.017) 
2.49e-28 
-0.445 (± 
0.016) 
9.51e-28 
-0.496 (± 
0.045) 
5.88e-14 
-0.456 (± 
0.031) 
4.9e-18 
  
Electronic 
P-value 
0.645 (± 
0.052) 
1.18e-15 
4.211 (± 
0.926) 
4.78e-05 
-5.272 (± 
2.052) 
0.0138 
0.735 (± 
0.984) 
0.459 
  
Field/Other 
P-value 
1.302 (± 
0.083) 
4.26e-19 
-4.051 (± 
1.051) 
0.000402 
6.288 (± 
2.380) 
0.0115 
-0.0769 (± 
1.071) 
0.943 
  
Other 
P-value 
 1.502 (± 
0.089) 
4.6e-20 
 1.307 (± 
0.110) 
6.84e-15 
  
Adjusted 
R
2
 
0.954 0.966 0.734 0.949   
df 45 45 45 45   
n 46 46 46 46   
F 
P-value 
315.577 
8.01e-29 
318.447 
2.79e-30 
42.472 
8.77e-13 
211.285 
8.94e-27 
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Figure 18. RB Es-σp-R regression predicted pKa versus pKa of di-ortho derivatives 
 
                                                                 
Unlike for R6G derivatives where sterics were almost 3/4
ths 
of the contribution to the pKa, with 
RB derivatives Es only contributed 58.597%. With σp and R supplying the remaining 26.472% 
and 14.931% respectively, RB has almost equivalent contributions from sterics and electronics. 
The weighting of the R, resonance effect, was also greater for RB derivatives which matches the 
regressional preference for R over F in the RB series given that that preference was not so 
distinct in the R6G series. 
 In conclusion, as expected R6G derivatives demonstrated a greater dependence upon 
steric parameters than RB derivatives. Our regressions did have a greater fit with the σI model 
suggested by Bijloo for use with anilines; however, the correlation between the σI and F as well 
as with R made the coefficients inaccurate, thereby overstating the role of electronics in the 
pKa.
26
 It does not appear that Bijloo checked the VIFs or the expected contributions of steric and 
electronic parameters in his work so he might have inadvertently sacrificed accuracy in the 
coefficient weighting for fit.
26
 While the Fujita-Nishioka equation did have good correlation, the 
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coefficients for R substituted for F are likely more accurate in these models.
22
 A kinetics test 
would assist in confirming the accuracy of the proposed modification, as the Fujita-Nishioka 
equation is based on kinetics. A three parameter model is best as four parameter models add up 
the multicollinearity within the proposed equation, making it less accurate. 
Though RB derivatives are easier to synthesize and have higher yields, R6G derivatives 
have more intense fluorescence and respond better to mathematical modeling. Therefore, R6G 
derivatives should be the preferred focus of future rhodamine pH probes. Though the models had 
high adjusted R
2
 values of 0.981 and 0.950 for R6G and RB derivatives respectively, these 
values are lower than the R
2
 values found by Fujita and Nishioka for their system and Bijloo for 
his.
22,26
 As stated above, these high correlations between predicted and experimental values 
might be at the cost of accuracy in the coefficients but regardless there is still room for 
improvement in the rhodamine models. A further study of electronic and steric parameters could 
assist, though I suspect that no present parameter would completely fit our data without affecting 
our coefficients in a negative manner. 
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D. Mathematical prediction of RB mono-ortho pKa 
 Since the mono-ortho compounds only have one ortho group, their electronic and steric 
parameters were not doubled as was done with the di-ortho derivatives. The parameters for the 
mono-ortho series are shown in Tables 11 and 12. As mentioned in the discussion of the pKa  
Table 11. Steric parameters for modeling mono-ortho series 
Substituent A
8
 Es
9
 υ
10
 V
a10 
I
X-H
 kJ/mol
11
 
H 0.00 0.00 0.00 0.00 4.00 
F 0.15 -0.46 0.27 1.22 19.2 
Cl 0.43 -0.97 0.55 2.54 38.1 
Me 1.70 -1.24 0.52 2.84 40.4 
iPr 2.15 -1.71 0.76 5.74 52.6 
Table 12. Electronic parameters for modeling mono-ortho series 
 
Substituent σp
9 σo
12
 F
9 
R
9 σI
9 σI
mod13
 
H 0.00 0.00 0.00 0.00 0.00 0.00 
F 0.06 0.29 0.43 -0.34 0.52 0.52 
Cl 0.23 0.50 0.41 -0.15 0.47 0.47 
Me -0.17 -0.13 -0.04 -0.13 -0.05 0.00 
iPr -0.15 -0.15 -0.05 -0.10 -0.06 0.00 
                                                             
8
 http://chem.wisc.edu/areas/organic/index-chem.htm 
9
 Fujita, T. and Nishioka, T. The Analysis of the Ortho Effect. Prog. Phys. Org. Chem. 1976, 12, 49-89. 
10
 Smith, M. B. and March, J. March’s Advanced Organic Chemistry: Reactions, Mechanisms, and Structure. John 
Wiley & Sons. 2007. 
11
 Bott, G.; Field, L. D.; and Sternhell, S. Steric Effects. A Study of a Rationally Designed System. J. Am. Chem. 
Soc. 1980, 102, 5618-5626. 
12
 Tribble, M. T. and Traynham, J. G. Nuclear Magnetic Resonance Studies of ortho-Substituted Phenols in 
Dimethyl Sulfoxide Solutions. Electronic Effects of ortho-Substituents. Journal of the American Chemical Society. 
1969, 91(1), 379-388. 
13
 Bijloo, G. J. and Rekker, R. F. Some Critical Remarks Concerning the Inductive Parameter σI Part IV: 
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values previously, the mono-ortho series does not seem to be as impacted by sterics. This was 
confirmed through regressions as all of the regressions containing a steric parameter had large p-
values for that parameter. Regressions were run instead using only electronic parameters. Only 
those regressions with p-values of less than 0.01 were included in Table 11. 
 The graphs of the mono-ortho pKa values versus σp and σo showed the closest to linear fit 
(Figures 19 and 20). In both graphs though, it appears as though the electron donating and 
electron withdrawing groups have different slopes. The graph versus σo shows the best linear 
shape as a result, though it is less linear overall as compared to the electron withdrawing groups 
in the graph versus σp. This observation is supported by the regression analysis since the 
regression against σo successfully places RB-2MA at a higher pKa than RB-2IA as was observed. 
σp did not; in that regression, RB-2MA and RB-2IA were predicted to be essentially the same, 
with RB-2IA slightly larger. Though the experimental values for the two compounds were still 
very similar, the regression for σo had more points on the line, a better fit overall, and smaller p-
values. 
  
Figure 19. RB pKa data for mono-ortho substituents versus their σp values  
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Table 11.  Mono-ortho regression analysis 
 σp σI σI
mod
-R F σo  
Intercept 
P-value 
4.332 (± 0.008) 
8.47e-41 
4.311 (± 0.011) 
2.27e-38 
4.328 (± 0.012) 
3.39e-36 
4.310 (± 0.011) 
1.77e-38 
4.316 (± 0.009) 
1.38e-40 
 
Electronic 
P-value 
0.316 (± 0.065) 
0.000115 
0.140 (± 0.042) 
0.00371 
0.297 (± 0.062) 
0.000155 
0.170 (± 0.049) 
0.00271 
0.185 (± 0.037) 
8.32e-05 
 
Field/Other 
P-value 
  0.386 (± 0.125) 
0.00632 
   
Other 
P-value 
      
Adjusted R
2
 0.528 0.332 0.524 0.352 0.543  
df 20 20 20 20 20  
n 21 21 21 21 21  
F 
P-value 
23.382 
0.00115 
10.938 
0.00371 
12.008 
0.000486 
11.868 
0.00271 
24.795 
8.32e-05 
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Figure 20. RB pKa data for mono-ortho substituents versus their σo values 
 
                                  
 This equation contradicts Bijloo’s analysis of mono-ortho anilines as having an electronic 
and steric component.
26
 Most likely this is because the mono-ortho substituted aniline is in a 
position where it can twist to reduce steric strain on the spirolactam and xanthene rings, unlike 
what would occur in a plain aniline. The next section contains further evidence for this 
hypothesis through computational models. While the fit of this regression was best overall, RB-
2FA and RB-2MA are noticeably off the line of best fit (Figure 21). There is most likely another 
factor which would improve the regressional analysis, though it would be particularly hard to 
identify it without more data points to strengthen the regression. A further study of electronic 
parameters would be best for determining a better regression, though a kinetics study might also 
prove useful by providing another parameter with which to analyze the regression. 
 In conclusion, the mono-ortho substituted compounds have only an electronic component 
for the RB series, due to the aniline ring’s ability to twist to relieve steric strain. It would be 
interesting to see if this remains the case for mono-ortho R6G derivatives given their methyl  
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Figure 21. RB σo regression predicted pKa versus pKa of mono-ortho derivatives 
 
group, which proved to increase the contribution from steric parameters as compared to the RB 
derivatives in the di-ortho analysis. However, since the mono-ortho RB derivatives only rely on 
electronics and do not vary substantially, it is clear that they are not well suited for our desired 
purpose as they are not high enough to work well in the acidic region. 
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Section III. Crystal structure and Gaussian modeling 
A. Crystal Structure for RB-DIA 
 Our interest in determining the 3D structure of our compounds arose from noting non-
equivalent isopropyl protons in RB-DIA and R6G-DIA. This indicated that the compound was 
twisting so as to create non-equivalence with certain substituents.  
 
Figure 22. RB-DIA aliphatic region with arrows pointing to the non-equivalent isopropyl peaks 
 Several samples of RB-DIA were dissolved into various solvents and left covered in an 
NMR tube at room temperature for approximately seven months in order to grow crystals (see 
Table 12). The amount of solvent used was about 2.5 mL. Only one sample was successful, RB-
DIA in 5:1 DCM:MeOH. Other suggestions include dissolving the rhodamines in a compound 
that they aren’t very soluble in and leaving in the freezer. This slows the rate of solvent  
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Compound Solutions Crystals 
RB-DIA CDCl3 No 
RB-DIA 1:1 EtOH:H2O No 
RB-DIA 5:1 DCM:MeOH Yes 
RB-DCPA 5:1 DCM:MeOH No (powder) 
RB-DIA EtOH No 
 
Table 12. Crystal growing experiment results based on solution 
 
evaporation which allows the big crystals needed for x-ray diffraction to form. Mixtures of 
solvents work best, particularly a combination of a solvent which rhodamine dissolves in and one 
which it doesn’t with a ratio favoring the solvent rhodamine is not soluble in. Once again the 
intention is to slow the rate of evaporation so that the environment is hospitable for crystal 
growth. I found that smaller diameter tubes, approximately the size of NMR tubes, covered with 
a cap where useful to grow crystals. The cap helped slow the rate of evaporation and the tube 
could be covered in tin foil to protect the rhodamine crystals from light. 
X-ray crystallography of the crystal was performed and analyzed by Dr. Robert D. Pike 
(see Figure 23). The full data from the analysis is available in Appendix D. The crystal structure 
clearly shows a xanthene bend, caused by the positioning of the aniline substituent out of the 
spirolactam ring plane. The interplanar angle between the xanthene and spirolactam rings is 
32.15 degrees. In essence, the spirolactam ring sits perpendicular to the xanthene ring. However, 
due to the xanthene bend the xanthene ring is not entirely planar. This xanthene twist is 154.8 
degrees, which makes it 25.2 degrees off from completely planar (planar being 180 degrees). 
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Figure 23. Crystal structure of RB-DIA 
 
The N-phenyl sits at a 93.67 angle from the spirolactam ring. As I was unable to grow any other 
crystals, these values were used to test the accuracy of a theoretical model of RB-DIA so as to 
determine the best calculations for computational models of the di-ortho RB and R6G series. The 
xanthene twist and N-phenyl coplanarity with the carbonyl can then be compared to determine 
how those angles affect the pKa. The structures will certainly model steric parameters which we 
already proved had a significant impact for both RB and R6G di-ortho compounds. Given that 
sterics played a greater role in the pKa of the R6G derivatives, I suspect the angles for those 
compounds will demonstrate a greater correlation with the pKa. 
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B. Computation models of RB and R6G di-ortho substituted derivatives 
 First, the crystal structure for RB-DIA was compared to the computation model of RB-
DIA to test the accuracy of the optimization to the HF/6-311(d,p) level when run using Gaussian. 
The actual angle of the xanthene twist was 152.363 degrees whereas the calculated angle was 
152.435 degrees. The values were close enough to declare this computation model accurate for 
rhodamine compounds. Of course, actual crystal structures would be preferred but given the 
difficulties in growing rhodamine crystals of the correct properties for x-ray diffraction  
  
Figure 24. Optimized structure of R6G-A (left) front view and (right) bird’s eye view 
 
 
Figure 25. Optimized structure of R6G-DFA (left) front view and (right) bird’s eye view 
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Figure 26. Optimized structure of R6G-DCA (left) front view and (right) bird’s eye view 
 
  
Figure 27. Optimized structure of R6G-DEA (left) front view and (right) bird’s eye view 
 
  
Figure 28. Optimized structure of R6G-DMA (left) front view and (right) bird’s eye view 
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Figure 29. Optimized structure of R6G-DIA (left) front view and (right) bird’s eye view 
  
Figure 30. Crystal structure of RB-A (left) front view and (right) bird’s eye view28 
 
Figure 31. Optimized structure of RB-DFA (left) front view and (right) bird’s eye view14 
                                                             
14
 Calculated by Grace E. Purnell 
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Figure 32. Optimized structure of RB-DCA (left) front view and (right) bird’s eye view14 
  
Figure 33. Optimized structure of RB-DEA (left) front view and (right) bird’s eye view 
  
Figure 34. Optimized structure of RB-DMA (left) front view and (right) bird’s eye view14 
68 
 
  
Figure 35. Optimized structure of RB-DIA (left) front view and (right) bird’s eye view14 
 
crystallography, these computation models are easier to generate. Grace Purnell calculated the 
majority of the RB set, with the exception of RB-DEA and RB-A, which was obtained from 
Deng and colleagues’ crystal structure.28 2D structures are available in Table 18. 
 Xanthene torsion found by averaging the value of the angle between C1-O1-C13-C12, 
C13-O1-C1-C2, C5-C6-C7-C8, and C9-C8-C7-C6 (see Figure 36). In terms of the xanthene 
twist, RB and R6G derivatives were essentially equal, which implies that the additional methyl 
group in R6G compounds does not impact the xanthene angle. As such, the xanthene angle is  
 
Table 13. RB and R6G derivatives by pKa, xanthene ring twist, A value, σp value, and Es 
Substituent RB 
pKa 
Xanthene R6G 
pKa 
Xanthene A value σp value ES 
H 4.31 172.576 3.81 172.964 0 0 0 
F 4.52 168.967 4.3 169.409 0.3 0.12 -0.92 
Cl 5.38 154.971 5.62 155.613 0.86 0.46 -1.94 
OEt 4.03 161.924 4.15 160.957 1.8 -0.48 -1.1 
Me 4.9 155.297 5.32 155.634 3.4 -0.34 -2.48 
iPr 5.72 152.435 5.87 153.234 4.3 -0.3 -3.42 
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Figure 36. The angles measured to calculate the xanthene twist 
 
most likely due to the substituent group. Theoretically, the xanthene angle should be the result of 
sterics, particularly the van der Waals repulsion. However, while the graph of xanthene angle 
versus Es was fairly linear (Figure 37), the graph versus A values (Figure 38) was much more 
so, with the exception of RB-DCA and R6G-DCA. As I mentioned in the previous chapter, A 
values had more of a relationship with the electronic measure σp than Es. So, that the xanthene 
twist is more linear plotted against A values implies that there is some relationship with  
 
Figure 37. Xanthene ring torsion for RB and R6G derivatives versus the Es parameter 
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Figure 38. Xanthene ring torsion for RB and R6G derivatives versus the A value parameter 
 
electronics which influences the angle twist. Only RB and R6G-DCA lie off of the line. This is 
likely due to the long bond length associated with chlorine and carbon. In R6G, this bond is 
1.735 Å as compared to the fluorine-carbon bond length of 1.317 Å. Since the angle of both 
groups off of the phenyl ring is approximately the same, it stands to reason that, due to its longer 
bond length, the chlorine group pushes the xanthene ring further away due to repulsion effects. 
Therefore, the xanthene ring angle is less when the rhodamine has DCA substituents. 
There is also clear distinction between the electron withdrawing and electron donating groups 
when graphed versus σp, thereby supporting the presence of electronic effects in the xanthene 
ring torsion. In fact, Figure 39 is nearly identical to the graph of σp versus pKa, only with a 
different slope. Within each electronic grouping, an increase in planarity induces ring opening, 
resulting in increasing pKa. 
As shown in the graph above, the xanthene ring twist was a fairly good model for pKa. A 
regressional analysis showed that R6G was better predicted by the xanthene angle than RB,  
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Figure 39. Xanthene ring torsion for RB and R6G derivatives versus the σp parameter 
 
 
Figure 40. RB and R6G derivatives pKa values versus their respective xanthene ring torsion  
 
which suggests that though the angle does incorporate some electronic effects it is primarily 
steric. Since R6G has a greater dependence on sterics, the prediction suits those derivatives 
better. Both the RB and R6G model overestimates the pKa for DEA and DMA, while 
underestimating all other pKa values. This trend does suggest that the model is primarily steric in 
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Table 14. Regression analysis on R6G and RB using xanthene twist as a parameter 
 R6G RB 
Intercept 
P-value 
20.137 (± 0.942) 
1.73e-23 
14.455 (± 1.152) 
3.94e-16 
Xanthene Angle Parameter 
P-value 
-0.094 (± 0.006) 
3.41e-19 
-0.0597 (± 0.007) 
1.27e-10 
Adjusted R
2 
0.865 0.604 
F 
P-value 
263.254 
3.41e-19 
69.731 
1.27e-10 
 
nature. We know the DIA substituents are large enough to overcome the stabilizing factor of an 
electron donating side group, however DEA and DMA are not. Hence, they have a lower pKa 
than would otherwise be expected based on their steric bulk alone. 
 Another factor looked at in the computational models was the coplanarity of the phenyl 
ring with the carbonyl group. This angle was measured as the angle between C20-N3-C21-C22 
(see Figure 41). As shown in the front views of the computational models, there is a distinct 
twist in the phenyl ring off the spirolatam ring which is dependent upon the substituents off of 
the phenyl ring. When graphed versus pKa (Figure 42) it is apparent that the majority of the 
compounds have an approximately 90˚ angle with the spirolactam ring, most likely due to the 
repulsion factors for their substituents. The exceptions are A and DEA for R6G and A, DFA, and 
DEA for RB. The angle for RB-A is substantially smaller than the angle for R6G-A. Either the 
methyl groups on the R6G do not allow the phenyl ring to twist as much or else our 
computational models are not as accurate as we would like them to be. Regardless, we can still 
determine that both RB-A and R6G-A do not lie close to a 90˚ angle with the carbonyl group. 
These trends are also evident when graphed against both Es and σp with little change 
(Figures 44 and 45). R6G, as noted before with the regressions, follows the trend more closely. 
If we assume that R6G-A is not a right angle because it has no bulky side groups to force a twist,  
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Figure 41. The angle between C20-N3-C21-C22 
 
 
Figure 42. pKa versus RB and R6G derivatives measure of coplanarity with the carbonyl  
 
Substituent RB pKa 
C20-N3-
C21-C22 
R6G pKa 
C20-N3-C21-
C22 
H 4.31 40.31 3.81 101.452 
F 4.52 80.519 4.3 88.268 
Cl 5.38 89.008 5.62 88.412 
OEt 4.03 76.917 4.15 107.42 
Me 4.9 88.628 5.32 88.351 
iPr 5.72 88.646 5.87 88.148 
 
Table 15. RB and R6G derivatives by pKa and coplanarity with the carbonyl 
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then R6G-DEA is the main outlier. Both of these compounds also possess the lowest pKa values. 
Perhaps than the more coplanar the phenyl ring is, the greater the strain is placed on the 
spirolactam ring. Unfortunately, this does not explain the variation in RB-DFA, other than the 
fact that the regression makes it clear that RB is less mathematically compliant. There appears to 
be some other factor in the RB model, most likely an electronic one, which would account for 
this difference. 
 
Figure 43. RB and R6G derivatives measure of coplanarity with the carbonyl versus the Es 
parameter  
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Figure 44. RB and R6G derivatives measure of coplanarity with the carbonyl versus the σp 
parameter 
 
  
40
50
60
70
80
90
100
110
120
-0.6 -0.4 -0.2 0 0.2 0.4 0.6
C
20
-N
3-
C
21
-C
22
 
σp Value 
N-phenyl coplanarity w/ C=O vs σp 
Value 
RB
R6G
76 
 
C. Computational models of RB mono-ortho substituted derivatives 
  
Figure 45. Optimized structure of RB-2CA (left) front view and (right) bird’s eye view 
  
Figure 46. Optimized structure of RB-2MA (left) front view and (right) bird’s eye view 
  
Figure 47. Optimized structure of RB-2IA (left) front view and (right) bird’s eye view 
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 Since the mono-ortho compounds were best modeled by electronic parameters only, it 
stands to reason that they won’t have much correlation with either xanthene ring twist or 
coplanarity with the carbonyl. The mono-ortho substitution does mean that the phenyl ring can 
twist to avoid steric strain with the xanthene ring so as expected, the xanthene ring is more planar 
in structure (Table 16). As with the di-ortho derivatives, the mono-ortho compounds are 
extremely linear in nature when graphed against A values (Figure 48) and slightly less linear 
when graphed against Es (Figure 49). This supports the theory that the xanthene ring twist is 
primarily a steric parameter but has some electronic contributions as well. Indeed, the graph of 
the mono-ortho compounds versus σp (Figure 50) is very similar to that of the di-ortho  
 
Table 16. RB mono-ortho derivatives by pKa, xanthene ring twist, A value, σp value, and Es 
Substituent RB pKa Xanthene A value σp value Es 
H 4.31 172.576 0 0 0 
Me 4.31 165.987 1.7 -0.17 -1.24 
iPr 4.28 164.369 2.15 -0.15 -1.71 
Cl 4.43 169.494 0.43 0.23 -0.97 
 
 
Figure 48. Xanthene ring torsion for RB mono-ortho derivatives versus A values 
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Figure 49. Xanthene ring torsion for RB mono-ortho derivatives versus the Es parameter 
 
 
Figure 50. Xanthene ring torsion for RB mono-ortho derivatives versus the σp parameter 
 
compounds, where the trends are split for electron withdrawing and donating groups. Of course, 
it is hard to make any definitive statement about these trends as only two compounds from each 
group were included in this analysis. As we have determined that the xanthene ring torsion is 
primarily the result of steric effects and the mono-ortho compounds were best modeled with only  
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Table 17. RB mono-ortho derivatives by pKa and coplanarity with the carbonyl 
 
Substituent RB pKa C20-N3-C21-C22 
H 4.31 40.31 
Me 4.31 71.966 
iPr 4.28 76.942 
Cl 4.43 71.794 
 
electronic effects, the xanthene ring twist does not correlate well with pKa.  
Even though the pKa of RB-A is the same as for RB-2MA, it is clear from their 
respective angles with regards to the spirolactam ring that there is a distinct difference in their 
orientation. Once again, it is possible that our computational models vary in some manner from 
the actual crystal structures of the molecules. However, the RB-2MA has a methyl group off the 
phenyl ring which would prohibit it twisting too much or else risk interference with the carbonyl 
itself. Since RB-A only has hydrogens in the ortho positions it doesn’t have this same concern. 
That explanation also accounts for why RB-2IA lies closer to a right angle with the spirolactam 
ring as it has the greatest steric bulk. 
 As shown on the next page in Figure 51, there is a slight linearity between steric bulk 
and the coplanarity with the carbonyl. The bigger the side group, the closer to a 90˚ angle the 
phenyl ring is with the spirolactam ring. Once again though, as this is a steric parameter it does 
not explain the pKa differences. Just as with the xanthene ring, there appear to be clear trends 
when the coplanar angle is graphed against the electronic parameter of σp (Figure 52). This 
indicates that there is a strong electronic effect, which we already knew from the regression. 
However, since there are only two points for electron withdrawing and electron donating groups  
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Figure 51. RB mono-ortho derivatives measure of coplanarity with the carbonyl versus Es 
parameter  
 
 
Figure 52. RB mono-ortho derivatives measure of coplanarity with the carbonyl versus σp 
parameter  
 
respectively we are unable to reach support any conclusion. Unfortunately, there is no evidence 
to support the theory that the more coplanar the phenyl ring is, the greater the strain is placed on 
the spirolactam ring. RB-2IA has a lower pKa than RB-A yet RB-A is more coplanar. It is 
possible that explanation only accounts for the di-ortho series, where sterics is a more important 
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factor. Therefore, computational modeling provides better insight into pKa for the di-ortho series, 
given that it is a primarily steric indicator.  
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Section IV. Nano incorporation of RB-DIA dyes 
 As mentioned in the introduction, conjugated polymer nanoparticles (CPN) can serve as a 
vector for transmission of the rhodamine dyes to cancer cells or other targets. The particular 
polymer I used with my rhodamine dyes was poly[(9,9-dioctylfluorenyl-2,7-diyl)-alt-co-(1,4-
benzo-{2,1’,3}-thiadiazole)], called PFBT from here on (Figure 53). This polymer was 
combined with a protective coating poylmer poly(vinyl butyral-co-vinyl alcohol-co-vinyl 
acetate), also known as PVCoCo (Figure 54). 
 
  
Figure 53. Structure of PFBT    Figure 54. Structure of PVCoCo 
 While the coating polymer is non-fluorescent and only serves to protect the nanoparticle, 
PFBT is fluorescent. By incorporating a dye molecule into the nanoparticle we aim to intensify 
its fluorescence by exciting the dye through the polymer through a process known as 
fluorescence resonance energy transfer (FRET). The fluorescence emission spectrum of PFBT 
overlaps with the absorbance spectrum of RB. As such, the donor, PFBT, can transfer its energy 
to the acceptor, the rhodamine dye, thereby increasing the rhodamine’s fluorescence. Since the 
PFBT’s absorbed energy is being transferred to the rhodamine, the fluorescence intensity of the 
PFBT will drop. FRET depends on distance; the donor and accepter molecules must be close 
together for FRET to occur. Therefore it is necessary to have the rhodamine molecules in or on 
the nanoparticle. The goal for this project was to incorporate RB-DIA, one of our higher pKa 
dyes, into a nanoparticle so that FRET can occur. Since the FRET amplifies the intensity of the  
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Figure 55. The addition of acid switches the fluorescence of the CPNs from the green region to 
the red as FRET occurs between PFBT and RB-DIA 
 
acceptor molecule, we can use smaller concentrations of RB-DIA, which would reduce the risk 
of toxicity. 
 Our lab has modified its nanos procedure since the first testing of one of our di-ortho RB 
compounds in a nano particle. A major component of this change involves the method of 
tetrahydrofuran (THF) removal. The polymers are first dissolved into THF to make the pre-nanos 
solution. Nanos are not formed until water is added, whereupon the hydrophobic PFBT curls to 
form a spherical nanoparticle. The THF must then be removed from the sample. Our old 
procedure used high vacuum pumping to remove the THF however we were finding that there 
was still a distinctive smell of THF from the nano solution even after the water was beginning to 
be removed from the sample. As a result, Matthew McCarron developed a method of removing 
the THF through argon bubbling. This method is more regulated than the previous procedure, 
where the nano solution was placed under high vacuum pumping until THF could no longer be 
smelled. Now, the solution is weighed before and after to help quantify the amount of liquid lost. 
Since the high vacuum pump’s pressure depended on how many solutions were on the line and 
H
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-
 
FRET 
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the seals of that line, the argon bubbling is also more consistent as we are able to control the 
bubbling rate. 
Old Nanos Procedure: 
 Prepare pre-nano solution with PFBT and PVCoCo. PFBT is dissolved in THF in a 1 
mg:1 mL ratio and stirred under argon gas for 2 hours. PVCoCo is also dissolved in THF 
in a 1:1 ratio and stirred for 20 minutes. 
 Filter PFBT solution with 0.7 μm filter. 
 Take 0.45 mL PFBT solution and add 24.1 mL THF and 0.45 mL of 1 mg dye in 10 mL 
THF solution. 
 Place 1 mL of this solution into 8 mL of ultrapure water and sonicate for 2 minutes (after 
sonicating both separately for 30 seconds first). 
 High vacuum pumping to remove THF. 
 Filter nano solution with 0.2 μm and 0.7 μm filter. 
New Nanos Procedure: 
 Prepare 1:1 stock of PFBT and 1:1 stock of PVCoCo. Stock of PVCoCo needs to stir for 
at least 24 hours prior while stock of PFBT needs to stir for 2 hours prior. 
 Best ratio of PVCoCo stock to PFBT stock is 1:2.6 so take 1000 μL of stock PFBT, 390 
μL of PVCoCo, and 2361 μL THF (anhydrous) (diluting to 25 mL with THF) and filtered 
with 0.7 μm paper. Note that the total amount can be halved or quartered so long as the 
ratios of PFBT and PVCoco are kept the same and THF is still used to dilute to the 
desired amount. Reducing the amounts used reduces waste as only 2 μL are used for the 
tested sample. 
 Sonicate 1 mL of this pre-nano solution and 8 mL of nano-pure water separately for 30 
seconds before pouring the ultrapure water into the pre-nano solution and sonicating for 2 
minutes. 
 Pour nanos into a dark vial and mass. 
 Remove THF with argon bubbling for 30 minutes while heating to 65˚C. Mass vial again 
to ensure the complete removal of THF. 
 Add 3.6 μL of dye solution (10 mg dye in 1 mL THF). 
 Filter with 0.2 μm and 0.7 μm filter paper. 
Using the new procedure, the nanoparticles should have a formula of 400 ppm PFBT, 90 wt% 
RB-DIA, and 2.6:1 PFBT:PVCoCo. 
400 ppm PFBT in solution= 0.04 mg PFBT/mL * 25 mL total solution= 1 mL PFBT 
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Figure 56. PFBT UV-Vis spectrum 
 
1 mL PFBT/2.6= 0.385 mL PVCoCo 
0.9 *0.04 mL PFBT= 0.036 mL RB-DIA/(10 mg/mL)= 0.0036 mL RB-DIA 
This ratio of dye to polymer is rather large, which could indicate that not all the dye is in or on  
the nanos. Also, since we are injecting THF with the dye, the THF could be stabilizing the nano 
further or keeping the dye solution suspended instead of incorporating the dyes into the nanos. 
 I created a different set of nanos, adding the dye before the first filter step. In this set, all 
the THF should be removed from the sample as opposed to the first procedure. 
Pre-Argon Bubbling Dye Addition: 
 250 μL of PFBT 
 96 μL PVCoCo 
 5904 μL THF 
 2.5 μL RB-DIA (10 mg/1 mL THF) 
This new set of nanos also has less dye, with 10 wt% RB-DIA instead of 90 wt%. Otherwise, the 
formula was not changed. 
400 ppm PFBT in solution= 0.04 mg PFBT/mL * 6.25 mL total solution= 0.250 mL PFBT 
86 
 
   
Figure 57. Post-argon bubbling addition of dye fluorescence, excitation at 450 nm (polymer 
peak on left, rhodamine on right) (red is pH 7.10 and pink is 4.59) 
    
Figure 58. Post-argon bubbling addition of dye fluorescence, excitation at 535 nm 
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0.250 mL PFBT/2.6= 0.096 mL PVCoCo 
0.1 * 0.250 mL PFBT= 0.025 mL RB-DIA / 10 mg/mL= 0.0025 mL RB-DIA 
To test whether or not the nanos were on or in the nanoparticle, we ran fluorescent scans at 450 
nm, exciting the polymer, and 535 nm, exciting RB-DIA. If the dyes are in the nano particle and 
undergoing FRET, the intensity of the rhodamine peak should be greater than if just the 
rhodamine is excited. For both the pre and post argon bubbling dye addition, the rhodamine peak 
was distinctly less intense when not excited through the nanoparticle. There appears to be very 
little difference between the two processes, though the ratio of polymer peak to rhodamine peak 
is greater for the post argon bubbling addition, as expected given the higher weight percent of 
RB-DIA. There was little difference seen in the UV-Vis spectrum for the dyes as well, though 
the point at which the rhodamine peak began to appear varied slightly. With the post-Ar addition 
of dye, the RB-DIA peak began to appear around a pH of 4.82, just before the nano began to 
degrade at 4.59 as evidenced by the bathochromic shift in the UV-Vis and fluorescence spectra. 
In comparison, the pre-Ar addition of dye had the RB-DIA peak appearing at 5.19 with the 
bathochromic shift beginning at 4.87. It appears that the THF does stabilize the nano slightly. 
While the process was reversible so that the addition of base increased the intensity of the 
polymer peak and decreased the intensity of the dye peak, the overall intensity was diminished at 
lower pH values, likely due to the degradation of the nano and this loss could not be restored. As 
can be seen in Figures 62 and 63 the overall intensity of the peaks are diminished after the first 
titration down with acid to a pH of 5.24. The intensity also noticeably decreases on the addition 
of base to change the pH from 8.49 to 9.21. The ratio of the peaks does remain approximately the 
same though. The nano set for Figures 62 and 63 also was a post-Ar addition of dye; the 
prescence of THF could explain the remarkable stability of the nanos as this set was tested after 
two days. Both previous sets mentioned were used within a day of making the nano solution. 
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Figure 59. Pre-argon bubbling addition of dye fluorescence, excitation at 450 nm (polymer peak 
on left, rhodamine on right) (red line is pH 8.81 and pink line is 6.51) 
      
Figure 60. Pre-argon bubbling addition of dye fluorescence, excitation at 535 nm 
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Figure 61. Post-argon bubbling addition of dye UV-Vis spectra (red line is pH of 7.10, grey is 
4.82, and green is 4.59); the small bump just below 600 nm is the rhodamine peak 
 
Figure 62. Pre-argon bubbling addition of dye UV-Vis spectra (red line is pH of 8.81, blue is 
5.19, and grey is 4.87); the small bump just below 600 nm is the rhodamine peak 
 
This age stability would be interesting to test further as the longer the nano stays stable 
for the easier it will be to use. To store these nanos for use I merely kept them in a dark vial, 
sealed the cap with Parafilm, and covered in tin foil before storing in the fridge. This protected 
the nanos from possibly degrading in the light. Unfortunately, while the THF does seem to  
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Figure 63. Two-day old nanos addition of acid fluorescence, excitation at 450 nm (polymer peak 
on left, rhodamine on right) (red is pH 7.30 and pink is 5.24) 
      
Figure 64. Two-day old nanos addition of base fluorescence, excitation at 450 nm (polymer peak 
on left, rhodamine on right) (red is pH is 5.24 and pink is 9.21) 
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positively affect stability of the nanos, it is not recommended for use in living biological 
systems.  
Since we cannot use THF to stabilize the nano, we must determine at what acidic pH the 
nanoparticle begins to degrade. To this end, we made a nano solution without any dye added and 
used argon bubbling to remove all the THF. We used the bathochromic shift in the UV-Vis 
spectra to mark the degradation of the nano, though intensity was lost prior to that as well. As 
can be seen in the fluorescence spectra (Figure 64), the intensity at first increased. Presumably 
the protonation from the acid addition at first increased the size of the nanos, thereby increasing 
the surface area of fluorescence. However, in the UV-Vis spectra the intensity of absorbance 
begins decreasing immediately. The fluorescence intensity began to drop before the 
bathochromic shift appeared in the UV-Vis spectrum at a pH of 4.70. This result appears fairly 
consistent with previous titrations of the nanoparticle with the RB-DIA dye where the shift began 
in the upper to mid 4.00 region. Unfortunately, this made accurately determining a pKa value 
difficult, particularly since the dye peak continued to increase in intensity at a pH of less than 5. 
Such an increase was expected as the dye used, RB-DIA, had a pKa of 5.72. With the 
bathochromic shift occurring at just below the pKa, the titration curve could not be completed by 
simply measuring the intensities of the rhodamine peak as we did in determining the pKa values 
for our compounds in solution. While the ratio between polymer and dye peak could be used to 
determine the pKa I would recommend an investigation into other polymers which overlap with 
the rhodamine spectra to see if there are any others which might be more stable at lower pH 
values. 
 The size of the nanoparticle was determined through dynamic light scattering (DLS). The 
number-weight Nicomp distribution gave 12.7 nm, 15.3 nm, and 14.4 nm diameters for an 
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average of 14.1 (see Figure 67). Based on previous tests in our lab on nanoparticle sizes, this 
sizing was what we would expect for these nanoparticles. 
      
Figure 65. PFBT and PVCoCo with no dye, addition of acid fluorescence, excitation at 450 nm 
(pH range of 6.60 to 3.93; red to pink line) 
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Figure 66. PFBT and PVCoCo with no dye, addition of acid UV-Vis spectra (red line is 6.60 
pH, dark green is 4.70, 4.29 is the light green line, and 3.93 is the pink line)  
 
Figure 67. Sample particle sizing of the PFBT and PVCoCo nanoparticle containing RB-DIA for 
a diameter of 14.4 nm using a DLS machine 
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Conclusions 
 While the synthesis procedure for R6G di-ortho derivatives is already optimized, the RB 
di-ortho synthesis procedure could use some modifications, chiefly a reduction in the amount of 
POCl3 used. This change should hopefully increase the percent yields. Otherwise, di-ortho 
compounds are clearly preferred to meta, para, and mono-ortho compounds for use in the acidic 
region of 4.5 to 6. R6G compounds in particular should be the focus of future research despite 
their synthetic hurdles as they have greater intensity than their RB counterparts and are more 
easily modeled mathematically. Their compliance with the mathematical model is likely due to 
the greater role of steric effects in their pKa values. RB appears to have an additional electronic 
parameter which is not fully accounted for in our models, hence its comparable lack of 
agreement with the mathematical model. 
For both compounds, a variation on the Fujita-Nishioka equation in which R is 
substituted for F is the best model (                 ). The mono-ortho compounds 
were best modeled by a sole electronic parameter of σo however, as they were also RB 
compounds, there remained an unexplained effect, presumably electronic in nature. Since the 
pKa of the mono-ortho compounds was dependent on electronic effects, their computational 
models did not give as much insight into their nature as the computational models for the di-
ortho compounds. 
Rhodamine dyes were successfully incorporated into a PFBT and PVCoCo nanoparticle 
and demonstrated FRET. However, the CPN was not as stable in low pKa values as this system 
would prefer. An investigation into other potential CPN systems is recommended for future 
studies. 
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Experimental 
RB-DNA 
 
RB-DMA 
 
RB-DIA 
 
RB-DFA 
 
*Synthesized by Grace Purnell 
RB-DCA 
 
*Synthesized by Grace Purnell 
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RB-DEA 
 
RB-2MA 
 
RB-A 
 
RB-2FA 
 
*Synthesized by Mona Rasooly 
RB-2CA 
 
*Synthesized by Mona Rasooly 
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RB-2IA 
 
*Synthesized by Mona Rasooly 
RB-4CA 
 
*Synthesized by Grace Purnell 
RB-DCPA 
 
RB-3,5CA 
 
*Synthesized by Grace Purnell 
RB-DCNA 
 
*Synthesized by William Czaplyski 
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2,6-diethoxynitrobenzene 
 
2,6-diethoxyaniline 
 
R6G-Acid 
 
R6G-A 
 
R6G-DFA 
 
*Synthesized by Grace Taumoefolau 
R6G-DCA 
 
*Synthesized by Grace Taumoefolau 
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R6G-DEA 
 
R6G-DMA 
 
*Synthesized by Grace Taumoefolau 
R6G-DIA 
 
Table 18. Structures and abbreviations for the rhodamine derivatives and precursors 
 
 The fluorescence spectra were recorded on a Varian Cary50 while the absorbance spectra 
were recorded on a Varian Eclipse. NMR studies were recorded on a Varian DD2 (
1
H 400 MHz, 
13
C 100 MHz) and referenced to TMS (
1
H) or CDCl3 at 77.0 (
13
C). MS analyses were performed 
on a Bruker 12.0 Tesla APEX-Qe FTICR-MS with an Apollo II ion source with positive 
electrospray ionization. These analyses were run by COSMIC Lab at Old Dominion University. 
Synthesis of RB-DNA: Rhodamine B (0.204 g) was dissolved in approximately 8 mL of 1,2-
dichloroethane (DCE) before being placed on magnetic stir plate while 0.3 mL of POCl3 was 
added drop-wise over the course of two minutes. Refluxed for four hours before rotovapping off 
the solvents. Sonicated for ten minutes after redissolving in 10 mL of DCE with top covered with 
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rubber stopper and needle to vent. Massed out 0.501 g of 2,6-dinitroaniline and added DCE to 
dissolve. Added this mixture drop-wise via syringe to the RB-acid chloride in the round bottom 
flask over the course of five minutes. Swirled occasionally while adding. Refluxed for twenty-
three hours and ten minutes. Rinsed with three washes of acid (2 M HCl) and four washes of 
base (2 M NaOH). Then rinsed with two washes of brine saturated solution. The aqueous layer 
was discarded after every wash. Several large scoops of magnesium sulfate (anhydrous) were 
added to the solution until the powder no longer clumped, forming a ‘snow globe’ effect when 
swirled. This step removed excess water. The solution was then funneled through filter paper 
into a round bottom and concentrated in vacuo. A semisolid substance formed in the solution 
before the solution formed a powder which coated the entire round bottom. After an NMR 
confirmed product, determined that 60:40 ethyl acetate (EtoAc) to hexane provided the best 
separation. Started a column at this separation before gradually increasing to 65:35 EtOAc to 
hexanes, then 70:30, and finally 80:20 right before the second band exited the column. 
Triethylamine was added to the column consistently in order to keep the rhodamine in its closed 
form as the acidic nature of the silica induced a ring opening. The first band was bright yellow 
(most likely aniline) while the second was a dark red, and the third a light pink. The second band 
indicated the possible presence of product on TLC. Concentrated in vacuo however had water 
enter the round bottom so also had to evaporate out the water. Dissolved in pure triethylamine 
with some acetone. At first this sample was a tan/yellow colored solution but as it was 
rotovapped it turned dark pink, indicating that the rhodamine had opened. NMR determined that 
this was likely product. Percent yield of 50.21%  but could not get to stay closed at a pH lower 
than about 15. 
1
H NMR (400MHz, CDCl3) 8.00-7.98 (d, 1H), 7.61-7.54 (m, 2H), 7.20-7.18 (d, 
1H), 6.59-6.57 (d, 2H), 6.44 (s, 2H), 6.35-6.32 (dd, 2H), 3.37-3.32 (m, 3H), 2.96-2.92 (m, 1H), 
101 
 
1.22-1.07 (m, 6H). 
13
C NMR (100 MHz, CDCl3) 170.0, 153.6, 149.8, 134.2, 129.2, 129.1, 125.0, 
124.4, 108.2, 106.3, 97.4, 45.0, 44.5, 12.5, 8.8. 
Synthesis of RB-DMA: Rhodamine B (0.2047 g) was dissolved in approximately 6 mL of DCE. 
Covered top with rubber stopper with needle to vent before adding 0.3 mL of POCl3 drop-wise 
over three minutes and swirled, followed by 0.15 mL DMA added drop-wise over two minutes. 
Refluxed for twenty-three hours and fifty-five minutes. The solution in the round bottom had 
separated into a lighter aqueous layer and a dark red lower layer. Concentrated in vacuo. Once 
the majority of the solution was removed, added chloroform and allowed to sit five minutes after 
mixing in a separatory funnel. Washed three times with acid (2 M HCl), three times with base (2 
M NaOH), and twice with brine. Added magnesium sulfate (anhydrous) and filtered to get a very 
light orange-tan solution. Rotovapped and took NMR to find strange anomalies. Dried under 
high vacuum pumping before taking another NMR to find pure product with some water. Percent 
yield was 23.50%. 
1
H NMR (400MHz, CDCl3) 8.09-8.07 (d, J= 7.4 Hz, 1H), 7.68-7.64 (m, 2H), 
7.43-7.42 (d, J= 7.4 Hz, 1H), 7.05-7.01 (t, J= 7.4 Hz, 1H), 6.84-6.82 (d, J= 7.4 Hz, 2H), 6.57-
6.55 (d, J= 9.0 Hz, 2H), 6.30-6.27 (dd, J= 8.8, 2.5 Hz, 2H), 6.23 (d, J= 2.4 Hz, 2H), 3.34-3.29 (q, 
J= 7.03, 8H), 1.35 (s, 6H), 1.14-1.11 (t, J= 7.03, 12H); 
13
C NMR (100 MHz, CDCl3) 166.0, 
155.9, 149.0, 148.6, 139.0, 132.1, 129.4, 128.7, 127.9, 127.7, 124.8, 123.9, 109.0, 107.4, 98.4, 
44.5, 18.3, 12.4; Exact mass calculated for C36H39FN3O2H
+
, 546.311504 m/z. Found 546.310670 
m/z. 
Synthesis of RB-2FA: Mona Rasooly synthesized RB-2FA. Measured out 0.2011 g RB and 
dissolved in 8 mL DCE. Added 0.3 mL POCl3 dropwise over five minutes and 0.18 mL 2-
fluoroaniline over one minute. Refluxed for twenty-three hours and twenty-five minutes. Added 
30 mL chloroform and washed with three times with acid (2 M HCl), three times with base (2 M 
102 
 
NaOH), and twice with brine. Concentrated in vacuo before running a column in 20:80 
EtOAc:Hexanes. Second band was product. Dried under high vacuum pumping. 
1
H NMR 
(400MHz, CDCl3) 8.04-8.02 (m, 1H), 7.55-7.49 (m, 2H), 7.19-7.17 (m, 1H), 7.15-7.10 (m, 1H), 
6.97-6.92 (t, J= 8.2, 1.2Hz, 1H), 6.86-6.83 (t, J= 7.65, 1.3 Hz, 1H), 6.72-6.69 (d, J= 9.0, 1.2 Hz, 
2H), 6.40-6.36 (td, J= 7.63, 5.5 Hz, 1H), 6.34-6.31 (dd, J= 9.0, 2.7 Hz, 2H), 6.24-6.23 (sd, J= 2.7 
Hz, 2H), 3.35-3.29 (m, 8H), 1.17-1.14 (t, J=7.05 Hz, 12H); 13C NMR (100 MHz, CDCl3) 166.9, 
153.5, 153.3, 148.8, , 132.8, 130.9, 129.3, 129.0/129.0, 128.2, 124.2, 123.8, 123.4, 116.3, 116.0, 108.1, 
106.0, 97.6, 67.6, 45.8, 44.3, 29.7, 12.5, 8.6. Exact mass calculated for C34H34N3O2H
+
, 536.270782 
m/z. Found 536.270232 m/z. 
Synthesis of RB-2CA: Mona Rasooly synthesized RB-2CA. Massed out 0.2064 g RB and 
dissolved in 8 mL DCE. Added 0.3 mL POCl3 dropwise over five minutes and 0.12 mL 2-CA 
dropwise over three minutes. Refluxed for twenty-four hours. Added 30 mL chloroform and 
washed three times with acid (2 M HCl), three times with base (2 M NaOH), and twice with 
brine. Concentrated in vacuo before running a column in 10:90 EtOAc:Hexanes. Second band 
was product. Dried under high vacuum pumping. 
1
H NMR (400MHz, CDCl3) 8.06-8.04 (m, 1H), 
7.58-7.52 (m, 2H), 7.25-7.22 (m, 2H), 7.11-7.07 (td, J= 7.63, 1.43 Hz 1H), 6.96-6.92 (td, J= 
7.63, 1.43 Hz, 1H), 6.75-6.73 (d, J=9.0 Hz, 1H), 6.64-6.62 (d, J= 8.6 Hz, 1H), 6.39-6.37 (dd, J= 
6.6, 2.4 Hz, 1H), 6.31-6.30 (sd, J= 2.4 Hz, 1H), 6.27-6.22 (td, J= 8.23, 1.83 Hz, 2H), 6.15-6.14 
(sd, J= 2.3 Hz, 1H), 3.38-3.35 (m, 4H), 3.29-3.25 (m, 4H), 1.26-1.10 (m, J= 6.95 Hz, 12H); 13C 
NMR (100 MHz, CDCl3) 166.0, 152.4, 134.3, 133.8, 132.7, 131.8, 130.9, 130.1, 129.5, 129.0, 128.7, 
128.3, 126.6, 124.3, 108.3, 107.5, 97.9, 97.4, 68.2, 44.4, 44.3, 29.7, 12.5. Exact mass calculated for 
C34H34ClN3O2H
+
, 552.241232 m/z. Found 552.241146 m/z. 
Synthesis of RB-2IA: Mona Rasooly synthesized RB-2IA. Massed out 0.2077 g RB and 
dissolved in 8 mL DCE. Added 0.3 mL POCl3 dropwise over five minutes and 0.2 mL 2-IA 
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dropwise over three minutes. Refluxed for forty hours and forty-five minutes. Added 30 mL 
chloroform and washed three times with acid (2 M HCl), three times with base (2 M NaOH), and 
twice with brine. Concentrated in vacuo before running a column. Dried under high vacuum 
pumping. 
1
H NMR (400MHz, CDCl3) 8.06-8.03 (m, 1H), 7.63-7.56 (m, 2H), 7.33-7.31 (m, 1H), 
7.21-7.13 (m, 2H), 6.85-6.81 (td, J= 6.85, 1.95 Hz, 1H), 6.62-6.57 (t, J= 10.4 Hz, 2H), 6.40-6.38 
(dd, J= 8.8, 2.5 Hz, 1H), 6.31-6.28 (dd, J= 9.0, 2.8 Hz, 1H), 6.26-6.25 (sd, J= 2.7 Hz, 1H), 6.16-
6.16 (sd, J= 2.4 Hz, 1H), 6.00-5.97 (dd, J= 7.85, 1.15 Hz, 1H), 3.44-3.21 (m, 8H), 2.59-2.52 (qui, 
J= 6.85 Hz, 1 H), 1.19-1.16 (t, J= 7.05 Hz, 6H), 1.14-1.08 (m, 9H), 0.44-0.43 (d, J= 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 166.7, 155.0, 154.3, 151.1, 148.9/148.9, 148.6, 133.0, 132.7, 132.4, 129.4, 
129.1, 128.9, 128.4/128.4, 126.1, 125.4, 124.5, 123.4, 108.2, 108.0, 107.9, 106.8, 98.0, 97.8, 68.2, 44.5, 
44.4, 28.3, 24.8, 23.1, 12.6, 12.5. Exact mass calculated for C35H41N3O2H
+
, 560.327154 m/z. Found 
560.326818 m/z. 
Synthesis of RB-4CA: Grace Purnell synthesized RB-4CA. This compound was reported 
previously
13
. 
Synthesis of RB-DCPA: Rhodamine B (0.2036 g) was dissolved in 5 mL of DCE. Covered the 
top with a rubber stopper with needle to vent before adding 0.3 mL POCl3 drop-wise over the 
course of three minutes while swirling constantly. Dissolved 0.54 g 2,6-dicyclopentylaniline in 5 
mL DCE and added this mixture to the rhodamine solution drop-wise over the course of fifteen 
minutes. Added approximately 3 mL more DCE since the solution was now a thick sludge. 
Refluxed for twenty-four hours and ten minutes. Very thick consistency, similar to that of a 
melted crayon, so concentrated in vacuo. Added 50 mL choloform before using Buchner 
filtration to separate out the gelatin like solid. Washed with 5 mL of chloroform four times 
before leaving under vacuum for an hour. Took the liquid and added 40 mL chloroform before 
washing with three washes of 2 M HCl, three washes 2 M NaOH, and two washes of brine. 
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Added magnesium sulfate anhydrous and filtered before rotovapping to get a dark red substance. 
Ran column in 60:40 EtOAc: Hexanes but had bands one and two run together to form a 
tan/white powder which later turned into a pinkish, cotton candy like powder. Ran another 
column in 80:20 EtOAc: Hexanes to get a tan and pink band. The tan band was run through a 
third column in the same ratio of solvents and concentrated in vacuo to get a tan powder which 
eventually turned white with a slightly pink tint.  Yield was 7%. 
Synthesis of RB-A: This compound was reported previously.
13
 Rhodamine B (0.2024 g) 
dissolved in approximately 6 mL of DCE. Covered the top with a rubber stopper with a needle to 
vent prior to adding 0.3 mL POCl3 drop-wise over the course of three minutes, while swirling. 
Added 0.15 aniline drop-wise over the course of two minutes, while swirling. Refluxed for 
twenty-four hours and fifteen minutes. Over the course of the reflux the mixture went from 
light/bubblegum pink to light red. Washed three times with 2M HCl, three times with 2M NaOH, 
and twice with brine. Added magnesium sulfate anhydrous before filtering and concentrated in 
vacuo to form a waxy red substance. Ran a column in 60:40 EtOAc: Hexanes and concentrated 
in vacuo the first band (tan) to form a yellow-tan solid with a bubbly appearance. Percent yield 
was 28.98% 
Synthesis of RB-DIA: Rhodamine B (0.2793 g) was dissolved in approximately 8 mL DCE 
before covering with a rubber stopper and needle to vent. Placed on a stir plate prior to adding 
0.3 mL POCl3 over the course of three minutes while stirring. Then added 0.25 mL 2,6-
diisopropylaniline drop-wise over the course of two minutes while stirring. Refluxed twenty-four 
hours and five minutes. Washed three times with 2M HCl, three times with 2M NaOH, and twice 
with brine. Added magnesium sulfate anhydrous and filtered before concentrating in vacuo. Ran 
a column in 70:30 EtOAc:Hexanes and collected the first band, which showed up pink on the 
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TLC. Concentrated in vacuo to get large quantities of white powder. Ran another column in 
60:40 EtOAc: Hexanes and got tan crystals with a faint white ring around the edge of the round 
bottom. Ran a third column in 40:60 EtOAc: Hexanes and collected the second band which 
formed a large amount of white power. Dried under high vacuum pumping. Percent yield was 
19.87%. 
1
H NMR (400MHz, CDCl3) 8.07-8.05 (m, 1H), 7.63-7.60 (m, 2H), 7.30-7.28 (m, 1H), 
7.24-7.20 (t, J= 7.8 Hz, 1H), 6.99-6.97 (d, J= 7.4 Hz, 2H), 6.56-6.54 (d, J= 9.0 Hz, 2H), 6.30-
6.28 (dd, J= 9.0, 2.7 Hz, 2H), 6.20 (d, J= 2.3 Hz, 2H), 3.32-3.26 (q, J= 7.0 Hz, 8H), 2.42-2.37 
(qui, J= 6.7 Hz, 2H), 1.13-1.09 (t, J= 7.1 Hz, 12H), 0.90-0.89 (d, J= 6.6 Hz, 6H), 0.44-0.43 (d, J= 
6.6 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) 167.3, 156.5, 149.4, 148.9, 148.7, 133.2, 132.0, 129.5, 
128.8, 128.5, 125.0, 123.7, 123.1, 108.9, 107.5, 98.4, 69.9, 44.4, 29.7, 26.7, 21.8, 12.6 
Synthesis of 2,6-Diethoxynitrobenzene: Using the synthesis developed by Carrol et al
29
, made 
a threefold reaction by dissolving 1.5252 2-nitroresorcinol into 30 mL of dimethylformamide 
(DMF) in a 100 mL round bottom. Added 2.7246 g of potassium carbonate, anhydrous. Placed 
under argon gas at room temperature with a needle to vent as started stirring. Dropwise addition 
of 1.7 mL ethyl iodine over the course of five minutes. Stirred for twenty-four hours before 
adding cold de-ionized water to the round bottom until the round bottom was full. A white/tan 
foam began appearing in the solution. Filtered using a Buchner funnel. The liquid was brown 
with white powder collecting in the funnel. Washed with cold water until there was 
approximately 175 mL in the filter flask. Let sit with vacuum for thirty minutes after the last 
drop of clear liquid into the filter flask. Massed into a clean glass vial by scooping powder in 
with a spatula. Percent yield was 96.18%. 
Synthesis of 2,6-Diethoxyaniline: Once again using the Carrol paper as the basis for the 
synthesis, massed out 0.3 g of 2,6-diethozynitrobenzene into a small 50 mL round bottom. 
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Added 10 mL of de-ionized water and stirred while adding 0.42 mL acetic acid. Then massed out 
0.83 g purified iron and added. [The iron was purified using the process given in Purification of 
Laboratory Chemicals.
30
 This process consisted of cleaning iron powder in 6M HCl using 
Buchner filtration before rinsing in a lot of de-ionized water. The last rinse was done with 
acetone and the powder was left to dry for an hour. Removed the powder than had turned orange 
and placed the grey/green powder in a glass vial.] Heated to reflux for one and a half hours at 
68˚C. Took off reflux and added 20 mL saturated NaHCO3. Then extracted three times with 30 
mL ethyl acetate. Top layer was yellow and clear while the bottom layer was dark. This top layer 
was concentrated in vacuo to form black oil with an almost blue-grey sheen to it. Dried 
overnight. Percent yield of 56.2%. 
Synthesis of RB-DEA: Massed out 0.2377 g RB and dissolved in 5 mL DCE. Added 0.3 mL 
POCl3 dropwise over two minutes while swirling. Dissolved 0.265 g DEA in 4 mL DCE. Added 
dropwise over five minutes. Refluxed for twenty-five hours and fifty minutes. Added 30 mL 
chloroform and washed three times with 2M HCl, three times with 2M NaOH, and twice with 
brine. Added magnesium sulfate and filtered before concentrating in vacuo to get a purple oil. 
Ran column in 60:40 EtOAc:Hexanes. First band was product. Formed a tan solid. Percent yield 
was 28.61%. 
1
H NMR (400MHz, CDCl3) 8.05-8.02 (m, 1H), 7.58-7.55 (m, J= 5.1, 1.15 Hz, 2H), 
7.29-7.27 (m, 1H), 7.05-7.01 (t, J= 8.4 Hz, 1H), 6.59-6.57 (d, J= 9 Hz, 2H), 6.26-6.22 (m, J= 8.6, 
2.7 Hz, 4H), 6.19-6.18 (d, J= 2.8 Hz, 2H), 3.68-3.61 (m, J= 7.0, 2.3 Hz, 4H), 3.33-3.26 (m, 8H), 
1.13-1.10 (t, J= 7.0 Hz, 12H), 1.04-1.01 (t, J= 6.9 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) 167.2, 
157.5, 154.8, 151.2, 148.2, 130.8, 130.7, 129.3, 128.0, 124.5, 123.3, 108.7, 106.8, 105.2, 103.9, 
97.4, 65.2, 63.1, 44.4, 14.5, 14.4, 12.6. Exact mass calculated for C38H43N3O4H
+
, 606.332633 
m/z. Found 606.332228 m/z. 
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Synthesis of R6G-acid: Massed out 1.022 g of R6G and 1.970 g of NaOH. Added 10 mL EtOH 
(absolute) and 20 mL DIH2O. Hooked up to condenser and heated to 90˚C with an oil bath. 
Refluxed for twenty hours and fifty minutes. Left to stir for two days. Added 10 mL 6M HCl 
slowly before placing in an ice bath to cool. Buchner filtered and left to sit in hood for an hour 
and a half before transferring to a glass vial using a spatula. Very wet, oily red product. Percent 
yield was 39.82%. 
Synthesis of R6G-A: Got a 100 mL round bottom and added ~4 scoops molecular sieves to it. 
Covered top with rubber stopper after adding a stir bar. Added needle to vent. Flame dried for 
approximately 3 minutes while hooked up to argon gas. The heat from the flame activates the 
molecular sieves. Left to cool as massed out 0.2003 g R6G-acid (prepared by Grace T.) into a 
small Erlenmeyer. Crushed the R6G-acid with a spatula and added 20 mL anhydrous 1,2-
dichloroethane before sonicating. Added 10 mL of anhydrous 1,2-dichloroethane to the round 
bottom while stirring before adding the 20 mL from the Erlenmeyer. Added another 20 mL of 
1,2-dichloroethane to the Erlenmeyer, once again crushing the R6G-acid and sonicating. Added 
to the round bottom. Crushed the remaining R6G-acid as much as possible, then added 10 mL 
1,2-dichloroethane and sonicated. Added to round bottom. Left the mixture in the round bottom 
to stir overnight under argon. After approximately 24 hours placed the solution in an ice bath. 
While still stirring and under argon, added 0.3 mL aniline and left to stir for 30 minutes. After 30 
minutes, added 0.05 ml POCl3 dropwise. Product almost instantly formed as tested by TLC 
plates. Left mixture to stir overnight under argon in the ice bath. Mixture went from bubblegum 
pink to orangish with the addition of POCl3. The next day, removed the melted ice bath and left 
to stir for another 24 hours. Removed from stir plate and shut off argon gas before setting up a 
Buchner filtration. Washed with 1,2-dichloroethane (not dry) until liquid dripping into flask was 
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clear. Transferred the liquid to a large (500 mL) separatory funnel. Rinsed the flask with 1,2- 
dichloroethane and continued transferring to the separatory funnel until the liquid in the flask 
was clear. Added 50 mL of chilled 2 M NaOH to the sep funnel and gently swirled while 
occasionally venting. Then took the bottom layer and discarded the top layer. Repeated three 
times. The mixture turned more orange in color with each wash. Started peach color and turned 
light orange. Then added 50 mL of brine to the sep funnel and gently swirled. Once again 
collected the bottom layer and repeated. Added several heaping scoops of anhydrous sodium 
sulfate to the product solution to dry. Did another Bunchner filtration, scooping the wet sodium 
sulfate onto the filter and rinsing with chloroform. Transferred to a large (500 mL) round bottom. 
Concentrated in vacuo to form red, oily ring on round bottom. Started column at 40:60 
EtOAc:Hexane and gradiated to 90:10 EtOAc:Hexanes. Product was orangey-brown powder. 
Percent yield was 5.12%. 
1
H NMR (400MHz, CDCl3) 8.04-8.02 (dd, J= 5.5, 2.6 Hz, 1H), 7.52-
7.48 (dt, J= 8.6, 3.6 Hz, 2H), 7.12-7.06 (m, 4H), 6.77-6.74 (dd, J= 7.8, 2.0 Hz, 2H), 6.44 (s, 2H), 
6.22 (s, 2H), 3.18-3.13 (q, J= 7.1 Hz, 4H), 1.93 (s, 6H), 1.32-1.28 (t, J= 7.1 Hz, 6H), 1.25 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) 167.7, 153.3, 151.5, 147.3, 136.6, 132.9, 131.0, 128.6, 128.5, 
128.1, 127.2, 126.6, 124.0, 123.4, 117.8, 106.9, 96.6, 67.5, 38.3, 29.7, 16.8, 14.7. Exact mass 
calculated for C32H31N3O2H
+
, 490.248904 m/z. Found 490.248945 m/z. 
Synthesis of R6G-DEA: Added 4 scoops of molecular sieves and stir bar to 100 mL round 
bottom before stopping with a rubber stopper and needle to vent. Flame dried under argon gas. 
While cooling, massed out a little over 0.2 g R6G-acid into a small Erlenmeyer. Added 20 mL 
dichloroethane (DCE) and sonicated. Added 10 mL DCE to round bottom under argon. Starting 
stirring as added the 20 mL from the Erlenmeyer. Added another 20 mL DCE to Erlenmeyer, 
sonicated, and added to round bottom. Added 10 mL DCE to Erlenmeyer, sonicated, and added 
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to round bottom. Left mixture to stir overnight under argon. The next day, stuck the mixture in 
an ice bath while dissolved 0.27 g DEA in 5 mL DCE anhydrous. Added to the round bottom and 
after thirty minutes added 0.05 mL POCl3 dropwise. Left to stir for four days while monitoring 
with TLC but the TLCs didn’t change much. Turned off argon and set up Buchner filtration, 
washing with DCE. Worked up using four washes of 2 M NaOH and two washes of brine. 
Added several scoops of sodium sulfate anhydrous and did another Buchner filtration. 
Concentrated in vacuo to get a red oil. Ran a column in 30:70 EtOAc:Hexanes. Ran a second 
column in 10:90 EtOAc:Hexanes with a gradient to 40:60 EtOAc:Hexanes. Ran a third column 
in 10:90 EtOAc:Hexanes with gradient to 30:70 EtOAc:Hexanes. Ran a fourth column in 10:90 
EtOAc:Hexanes to get product. Percent yield was 9.65%. 
1
H NMR (400MHz, CDCl3) 8.07-8.05 
(m, 1H), 7.60-7.56 (m, J= 3.6 Hz, 2H), 7.25-7.21 (m, 1H), 7.04-7.00 (t, J=8.4 Hz, 1H), 6.39 (s, 
2H), 6.25-6.23 (d, J= 8.7 Hz, 2H), 6.17 (s, 2H), 3.65-4.59 (m, J= 9.2, 2.4 Hz, 2H), 3.39-3.29 (m, 
J= 9.4, 2.3 Hz, 2H), 3.17-3.12 (m, J= 7.1, 2.8 Hz, 4H), 1.92 (s, 6H), 1.30-1.26 (t, J= 7.1 Hz, 6H), 
0.98-0.950 (t, J= 6.9 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) 167.3, 157.5, 153.3, 151.8, 146.8, 
133.4, 132.0, 130.7, 129.1, 128.0, 124.6, 123.2, 115.9, 109.1, 104.4, 96.2, 68.4, 63.4, 38.4, 29.7, 
16.9, 14.8, 14.2. Exact mass calculated for C36H39N3O4H
+
, 578.301333 m/z. Found 578.301291 
m/z. 
Synthesis of R6G-DIA: Added 4 scoops of molecular sieves and stir bar to round bottom before 
stopping with a rubber stopper and needle to vent. Flame dried under argon gas for four minutes. 
Massed out 0.2067 g R6G-acid to which was added 20 mL of anhydrous DCE. Mixture was 
sonicated and 10 mL anhydrous DCE was added to round bottom. Added the 20 mL from the 
R6G-acid mixture than added 20 mL anhydrous DCE to the R6G-acid and sonicated again. 
Added to round bottom. Added 10 mL anhydrous DCE to R6G-acid, sonicated, and added to 
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round bottom. Left mixture to stir for twenty-four hours under argon gas. Placed in an ice bath 
and added 0.3 mL DIA. Allowed to stir under argon for thirty minutes before adding 0.05 mL 
POCl3 dropwise. Left to stir for forty-five hours, removing the ice bath once it had melted. 
Buchner filtered then washed with 2 M NaOH three times and brine once. Added anhydrous 
sodium sulfate and did another Buchner filtration. Concentrated in vacuo. Ran column in 40:60 
EtOAc:Hexanes to 90:10 EtOAc:Hexanes. Ran a second column with 40:60 EtOAc:Hexanes. 
Concentrated in vacuo to get white powder. Percent yield was 17.99%. 
1
H NMR (400MHz, 
CDCl3) 8.10-8.07 (m, 1H), 7.65-7.62 (m, J= 3.5 Hz, 2H), 7.25-7.24 (m, 1H), 7.22-7.18 (t, J= 7.9 
Hz, 1H), 6.96-6.94 (d, J= 7.8 Hz, 2H), 6.33 (s, 2H), 6.17 (s, 2H), 3.46 (s, 2H), 3.15-3.10 (q, J= 
6.8 Hz, 4H), 2.42-2.35 (qui, J= 6.6 Hz, 2H), 1.93 (s, 6H), 1.28-1.24 (t, J= 7.1 Hz, 6H), 0.89-0.87 
(d, J= 6.6 Hz, 6H), 0.37-0.35 (d, J= 6.7 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) 167.3, 154.9, 
150.0, 149.5, 147.3, 133.0, 132.1, 129.6, 128.8, 128.5, 125.0, 123.6, 123.0, 117.2, 109.0, 97.1, 
50.9, 38.3, 29.8, 26.8, 21.3, 16.8, 14.7. Exact mass calculated for C36H39N3O4H
+
, 574.342804 
m/z. Found 574.342140 m/z. 
Synthesis of RB-o-toluidine (aka RB-2MA): Massed out 0.2056 g RB into a 50 mL round 
bottom. Added 7 mL 2,6-dichloroethane (DCE) to dissolve before adding 0.3 mL POCl3 
dropwise over two minutes. Added 0.15 mL 0-toluidine dropwise over one minute. Refluxed for 
forty-nine hours and ten minutes. Added 30 mL chloroform and washed with 2x 2M HCl, 3x 2M 
NaOH, and 2x brine. Added anhydrous magnesium sulfate and filtered before concentrating in 
vacuo to get a pinkish-purple sludge which was waxy in consistency. Ran column in 30:70 
EtOAc:Hexanes to get product in the second band. Percent yield is 40.84%. 
1
H NMR (400 MHz, 
CDCl3) 8.06-8.04 (m, 1H), 7.62-7.55 (m, 2H), 7.32-7.29 (m, 1H), 7.10-7.02 (m, 2H), 6.87-6.83 
(td, J= 7.45, 1.55 Hz, 1H), 6.62-6.59 (dd, J= 8.8, 2.4 Hz, 2H), 6.40-6.38 (dd, J= 8.8, 2.5 Hz, 1H), 
111 
 
6.28-6.25 (dd, J= 9.0, 2.7 Hz, 2H), 6.17-6.16 (sd, J= 2.7 Hz, 1H), 6.06-6.04 (dd, J= 7.8, 1.2 Hz,  
1H), 3.40-3.26 (m, 8H), 1.26-1.16 (t, J= 7.05 Hz, 6H), 1.14-1.10 (t, J= 7.05 Hz, 6H); 
13
C NMR 
(100 MHz, CDCl3) 165.9, 154.7, 154.0, 151.4, 149.0, 148.2, 138.1, 134.3, 132.8, 132.5, 130.5, 
130.5, 129.7, 128.9, 128.6, 128.4, 128.4, 127.8, 127.8, 125.6, 125.6, 124.4, 123.4, 123.4, 108.2, 
107.9, 107.4, 106.7, 98.0, 97.8, 97.8, 68.1, 44.5, 44.4, 44.3, 18.4, 18.4, 12.5, 12.5. Exact mass 
calculated for C35H37N3O2H
+
, 532.295854 m/z. Found 532.295977 m/z. 
RB-DCNA: Synthesized by William Czaplyski and previously reported
13
. 
RB-3,5CA: Synthesized by Grace Purnell. 
RB-DCA: Synthesized by Grace Purnell using the procedure outlined in the synthesis chapter. 
1
H NMR (400 MHz, CDCl3) 8.08-8.07 (d, J= 6.6 Hz, 1H), 7.70-7.60 (tddt, J= 7.5, 1.4, 1.2 Hz, 
2H), 7.41-7.39 (d, J= 7.4 Hz, 1H), 7.14-7.05 (m, 3H), 6.61-6.59 (d, J= 8.6 Hz, 2H), 6.29-6.26 
(dd, J= 9.0, 2.7 Hz, 2H), 6.23 (d, J= 2.4 Hz, 2H), 3.34-3.29 (q, J= 7.1 Hz, 8H), 1.14-1.11 (t, J= 
7.1 Hz, 12H); 
13
C NMR (100 MHz, CDCl3) 166.2, 155.5, 149.6, 149.1, 137.3, 132.7, 132.6, 
131.6, 130.6, 129.6, 128.6, 128.3, 124.9, 123.9, 108.1, 107.6, 98.1, 70.2, 44.5, 12.4 
RB-DFA: Synthesized by Grace Purnell using the procedure outlined in the synthesis chapter. 
1
H NMR (400MHz, CDCl3) 8.04-8.01 (m, 1H), 7.60-7.53 (m, J= 7.4, 1.6, 1.2 Hz, 2H), 7.25-7.24 
(d, J= 1.6 Hz, 1H), 7.15-7.08 (tt, J= 8.5, 5.9 Hz, 1H), 6.71-6.67 (t, 8.5 Hz, 2H), 6.65-6.62 (dd, J= 
8.8, 1.7 Hz, 2H), 6.32-6.29 (dd, J= 9.0, 2.7 Hz, 2H), 6.21 (d, J= 2.3 Hz, 2H), 3.34-3.28 (qd, J= 
7.0, 2.3 Hz, 8H), 1.15-1.12 (t, J= 7.0 Hz, 12 H); 
13
C NMR (100 MHz, CDCl3) 167.3, 153.7, 
152.6, 148.8, 133.0, 131.3, 130.2, 130.1, 129.7, 128.4, 124.6, 123.4, 111.8, 111.5, 107.8, 106.0, 
97.4, 68.5, 44.4, 12.5 
R6G-DCA: Synthesized by Grace Taumoefolau using the procedure outlined in the synthesis 
chapter
19
. Percent yield 10-15%. 
1
H NMR (400MHz, CDCl3) 8.10-8.08 (dd, J= 6.3, 1.2 Hz, 1H), 
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7.70-7.62 (m, J= 7.4, 1.6 Hz, 2H), 7.35-7.33 (dd, J= 6.5, 1.0 Hz, 1H), 7.12-7.02 (m, 3H), 6.40 (s, 
2H), 6.19 (s, 2H), 3.39-3.11 (m, 4H), 1.92 (s, 6H), 1.31-1.27 (t, J= 7.3, 6H); 
13
C NMR (100 
MHz, CDCl3) 166.3, 153.9, 150.1, 147.6, 137.1, 132.8, 132.5, 130.8, 129.5, 128.6, 128.4, 124.9, 
123.9, 116.8, 108.2, 96.5, 70.3, 38.4, 16.7, 14.7. Exact mass calculated for C32H29Cl2N3O2H
+
, 
580.152904 m/z. Found 580.152346 m/z. 
R6G-DFA: Synthesized by Grace Taumoefolau using the procedure outlined in the synthesis 
chapter
19
. Percent yield was 5%. 
1
H NMR (400MHz, CDCl3) 8.06-8.04 (m, 1H), 7.60-7.55 (m, 
J= 5.1, 1.3 Hz, 2H), 7.21-7.19 (m, 1H), 7.12-7.08 (m, J= 8.4, 2.3 Hz, 1H), 6.69-6.65 (t, J= 8.9 
Hz, 2H), 6.45 (d, J= 1.2 Hz, 2H), 6.18 (s, 2H), 3.48 (s, 2H), 3.18-3.13 (q, J= 7.1 Hz, 4H), 1.94 (s, 
6H), 1.31-1.28 (t, J= 7.0 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) 167.4, 161.6, 159.0, 159.0, 
152.9, 152.1, 147.4, 133.1, 130.0/ 130.0, 129.7/ 129.6/ 129.5, 128.4, 124.5, 123.4, 117.25, 
111.8/111.6/111.5, 106.4, 96.0, 68.6, 38.3, 16.7, 14.7. Exact mass calculated for 
C32H29F2N3O2H
+
, 526.230060 m/z. Found 526.229075 m/z. 
R6G-DMA: Synthesized by Grace Taumoefolau using the procedure outlined in the synthesis 
chapter.
19
 Percent yield was 5%. 
1
H NMR (400MHz, CDCl3) 8.10-8.08 (m, 1H), 7.69-7.64 (m, 
J= 6.6, 1.2 Hz, 2H), 7.38-7.36 (dd, J= 6.1, 1.8 Hz, 1H), 7.03-7.00 (t, J= 7.5 Hz, 1H), 6.81-6.79 
(d, J= 7.5 Hz, 2H), 6.35 (s, 2H), 6.19 (s, 2H), 3.46 (s, 2H), 3.18-3.12 (m, J= 7.9 Hz, 4H), 1.93 (s, 
6H), 1.32 (s, 6H), 1.31-1.27 (t, J= 7.1 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) 166.0, 154.3, 149.1, 
147.5, 138.9, 133.5, 132.2, 129.6, 128.7, 127.9, 127.8, 124.9, 123.8, 116.8, 109.2, 96.9, 69.5, 
38.4, 18.3, 16.8, 14.6. Exact mass calculated for C36H39N3O2H
+
, 546.311504 m/z. Found 
546.310670 m/z. 
Drying Chloroform: Due to the continued presence of contaminants in the CDCl3, a new 
procedure was developed to purify the solvent. The stock solution (100 mL, Sigma-Aldrich) was 
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sealed with Parafilm and stored in the fridge. A pipet was used as a column, stuffed with glass 
wool then filled with anhydrous magnesium sulfate (MgSO4, Sigma-Aldrich) and potassium 
carbonate (K2CO3, Sigma-Aldrich). The potassium carbonate was used to interact with the 
hydrochloric acid (HCl) byproducts formed by the CDCl3 with the anhydrous magnesium sulfate 
removing the water produced by the acid-base reaction. Approximately six milliliters of the stock 
CDCl3 was run through this column into a small, dark vial filled halfway with molecular sieves. 
This vial was then sealed with Parafilm and covered with foil before being placed in a desiccator 
at room temperature for storage. The stock solution: 
1
H NMR (400MHz, CDCl3) 7.23 (s), 3.47-
3.46 (d, J= 4.3 Hz), 2.16 (s), 1.82 (s), 1.33 (s). The purified CDCl3: 
1
H NMR (400MHz, CDCl3) 
7.52 (s), 7.26 (s), 6.99 (s), 3.50 (br s), 1.54 (s). Only the chloroform and water peaks were of any 
significant height within the purified CDCl3 which was an improvement upon the chloroform 
and four additional peaks in the stock solution. However, the chloroform to water ratio was 
approximately equal (1:0.16) in both solutions. This amount of water was acceptable for NMR 
usage as it would be drowned out by dry compounds dissolved in the CDCl3.  
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Appendix A 
Figure A1: 
1
H NMR Spectrum of RB-DCA 
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Figure A2: 
1
H NMR Spectrum of RB-DCA (6.0-8.5 ppm) 
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Figure A3: 
1
H NMR Spectrum of RB-DCA (0-4.5 ppm) 
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Figure A4: 
13
C NMR Spectrum of RB-DCA 
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Figure A5: 
1
H NMR Spectrum of RB-DFA 
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Figure A6: 
1
H NMR Spectrum of RB-DFA (6.0-8.5 ppm) 
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Figure A7: 
1
H NMR Spectrum of RB-DFA (0-4.5 ppm) 
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Figure A8: 
13
C NMR Spectrum of RB-DFA 
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Figure A9: 
1
H NMR Spectrum of RB-DEA 
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Figure A10: 
1
H NMR Spectrum of RB-DEA (6.0-8.5 ppm) 
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Figure A11: 
1
H NMR Spectrum of RB-DEA (0-4.5 ppm) 
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Figure A12: 
13
C NMR Spectrum of RB-DEA 
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Figure A13: 
1
H NMR Spectrum of RB-DMA
15
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Figure A14: 
1
H NMR Spectrum of RB-DMA (6.0-8.5 ppm)
15 
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Figure A15: 
1
H NMR Spectrum of RB-DMA (0-4.5 ppm)
15 
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Figure A16: 
13
C NMR Spectrum of RB-DMA 
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Figure A17: 
1
H NMR Spectrum of RB-DIA 
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Figure A18: 
1
H NMR Spectrum of RB-DIA (6.0-8.5 ppm) 
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Figure A19: 
1
H NMR Spectrum of RB-DIA (0-4.5 ppm) 
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Figure A20: 
13
C NMR Spectrum of RB-DIA 
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Figure A21: 
1
H NMR Spectrum of R6G-A 
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Figure A22: 
1
H NMR Spectrum of R6G-A (6.0-8.5 ppm) 
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Figure A23: 
1
H NMR Spectrum of R6G-A (0-4.5 ppm) 
  
142 
 
Figure A24: 
13
C NMR Spectrum of R6G-A 
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Figure A25: 
1
H NMR Spectrum of R6G-DCA 
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Figure A26: 
1
H NMR Spectrum of R6G-DCA (6.0-8.5 ppm) 
  
145 
 
Figure A27: 
1
H NMR Spectrum of R6G-DCA (0-4.5 ppm) 
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Figure A28: 
13
C NMR Spectrum of R6G-DCA 
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Figure A29: 
1
H NMR Spectrum of R6G-DFA 
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Figure A30: 
1
H NMR Spectrum of R6G-DFA (6.0-8.5 ppm) 
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Figure A31: 
1
H NMR Spectrum of R6G-DFA (0-4.5 ppm) 
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Figure A32: 
13
C NMR Spectrum of R6G-DFA 
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Figure A33: 
1
H NMR Spectrum of R6G-DEA 
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Figure A34: 
1
H NMR Spectrum of R6G-DEA (6.0-8.5 ppm) 
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Figure A35: 
1
H NMR Spectrum of R6G-DEA (0-4.5 ppm) 
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Figure A36: 
13
C NMR Spectrum of R6G-DEA 
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Figure A37: 
1
H NMR Spectrum of R6G-DMA 
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Figure A38: 
1
H NMR Spectrum of R6G-DMA (6.0-8.5 ppm) 
  
157 
 
Figure A39: 
1
H NMR Spectrum of R6G-DMA (0-4.5 ppm) 
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Figure A40: 
13
C NMR Spectrum of R6G-DMA 
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Figure A41: 
1
H NMR Spectrum of R6G-DIA 
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Figure A42: 
1
H NMR Spectrum of R6G-DIA (6.0-8.5 ppm) 
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Figure A43: 
1
H NMR Spectrum of R6G-DIA (0-4.5 ppm) 
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Figure A44: 
13
C NMR Spectrum of R6G-DIA 
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Figure A45: 
1
H NMR Spectrum of RB-DCPA 
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Figure A46: 
1
H NMR Spectrum of RB-DCPA (6.0-8.5 ppm) 
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Figure A47: 
1
H NMR Spectrum of RB-DCPA (0-4.5 ppm) 
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Figure A48: 
1
H NMR Spectrum of RB-DNA
16
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Figure A49: 
1
H NMR Spectrum of RB-DNA (6.0-8.5 ppm)
16 
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Figure A50: 
1
H NMR Spectrum of RB-DNA (0-4.5 ppm)
16 
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Figure A51: 
13
C NMR Spectrum of RB-DNA
16 
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Figure A52: 
1
H NMR Spectrum of RB-2CA 
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Figure A53: 
1
H NMR Spectrum of RB-2CA (6.0-8.5 ppm) 
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Figure A54: 
1
H NMR Spectrum of RB-2CA (0-4.5 ppm) 
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Figure A55: 
13
C NMR Spectrum of RB-2CA  
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Figure A56: 
1
H NMR Spectrum of RB-2FA 
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Figure A57: 
1
H NMR Spectrum of RB-2FA (6.0-8.5 ppm) 
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Figure A58: 
1
H NMR Spectrum of RB-2FA (0-4.5 ppm) 
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Figure A59: 
13
C NMR Spectrum of RB-2FA  
  
178 
 
Figure A60: 
1
H NMR Spectrum of RB-2MA 
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Figure A61: 
1
H NMR Spectrum of RB-2MA (6.0-8.5 ppm) 
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Figure A62: 
1
H NMR Spectrum of RB-2MA (0-4.5 ppm) 
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Figure A63: 
13
C NMR Spectrum of RB-2MA 
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Figure A64: 
1
H NMR Spectrum of RB-2IA 
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Figure A65: 
1
H NMR Spectrum of RB-2IA (6.0-8.5 ppm) 
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Figure A66: 
1
H NMR Spectrum of RB-2IA (0-4.5 ppm) 
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Figure A67: 
13
C NMR Spectrum of RB-2IA 
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Figure A68: Stock solution of CDCl3 
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Figure A69: Purified CDCl3 
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Appendix B 
 
Figure B1: Sample fluorescence spectra for RB-A 
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Figure B2: Sample titration curve for RB-A 
 
 
 
Figure B3: Sample UV-Vis spectra for RB-A 
  
190 
 
 
RB-A pKa Max fl intensity Fl lmax 
 4.36 176 583 
 4.31 176 583 
 4.31 220 583 
 4.34 218 583 
 4.30 106 583 
 4.31 97 583 
 4.27 66 583 
Mean 4.314 151.286  
Std dev 0.024 24.839  
 
Table B1: pKa values for RB-A 
  
191 
 
 
Figure B4: Sample fluorescence spectra for RB-DFA 
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Figure B5: Sample titration curve for RB-DFA 
 
 
 
 
Figure B6: Sample UV-Vis spectra for RB-DFA 
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RB-DFA pKa Max fl intensity Fl lmax 
 4.41 333 582 
 4.44 368 582 
 4.46 267 582 
 4.50 349 582 
 4.62 280 582 
 4.58 309 582 
 4.54 353 582 
 4.58 434 582 
Mean 4.516 336.625  
Std dev 0.076 53.074  
 
Table B2: pKa values for RB-DFA 
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Figure B7: Sample fluorescence spectra for RB-DCA 
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Figure B8: Sample titration curve for RB-DCA 
 
 
Figure B9: Sample UV-Vis spectra for RB-DCA 
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RB-DCA pKa Max fl intensity Fl lmax 
 5.19 282 581 
 5.39 292 581 
 5.42 336 581 
 5.43 241 581 
 5.41 193 581 
 5.39 188 581 
 5.39 255 581 
 5.42 182 581 
Mean 5.38 246.125  
Std dev 0.078 55.917  
Note: Diluted 2x 
Table B3: pKa values for RB-DCA 
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Figure B10: Sample fluorescence spectra for RB-DEA 
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Figure B11: Sample titration curve for RB-DEA 
 
 
Figure B12: Sample UV-Vis spectra for RB-DEA 
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RB-DEA pKa Max fl intensity Fl lmax 
 3.96 210 583 
 4.03 215 583 
 4.12 166 583 
 4.09 171 583 
 4.04 167 583 
 3.93 166 583 
Mean 4.028 182.5 583 
Std dev 0.073 23.365  
 
Table B4: pKa values for RB-DEA 
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Figure B13: Sample fluorescence spectra for RB-DMA 
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Figure B14: Sample titration curve for RB-DMA 
 
 
Figure B15: Sample UV-Vis spectra for RB-DMA 
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RB-DMA pKa Max fl intensity Fl lmax 
 4.82 204 581 
 4.68 220 581 
 4.88 187 581 
 4.94 257 581 
 4.92 304 581 
 5.04 93 581 
 4.95 105 581 
 4.99 683 581 
Mean 4.903 256.625  
Std dev 0.112 186.226  
Note: Diluted 2x 
Table B5: pKa values for RB-DMA 
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Figure B16: Sample fluorescence spectra for RB-DIA 
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Figure B17: Sample titration curve for RB-DIA 
 
 
Figure B18: Sample UV-Vis spectra for RB-DIA 
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RB-DIA pKa Max fl intensity Fl lmax 
 5.87 898 582 
 5.75 620 582 
 5.67 552 582 
 5.74 549 582 
 5.53 586 582 
 5.64 611 582 
 5.93 562 582 
 5.61 647 582 
Mean 5.718 628.125  
Std dev 0.134 114.487  
 
Table B6: pKa values for RB-DIA 
 
  
206 
 
 
Figure B19: Sample fluorescence spectra for RB-DCPA 
 
In
te
n
si
ty
 (
a.
u
.)
 
Wavelength (nm) 
207 
 
 
Figure B20: Sample titration curve for RB-DCPA 
 
 
Figure B21: Sample UV-Vis spectra for RB-DCPA 
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RB-DCPA pKa Max fl intensity Fl lmax 
 4.96 10 580 
 4.92 10 580 
 5.04 57 580 
Mean 4.973 25.667  
Std dev 0.061 27.135  
 
Table B7: pKa values for RB-DCPA 
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Figure B22: Sample fluorescence spectra for R6G-A 
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Figure B23: Sample titration curve for R6G-A 
 
 
Figure B24: Sample UV-Vis spectra for R6G-A 
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R6G-A pKa Max fl intensity Fl lmax 
 3.83 431 555 
 3.83 500 555 
 3.83 267 555 
 3.79 295 555 
 3.80 340 555 
 3.79 355 555 
 3.81 467 555 
 3.82 421 555 
Mean 3.813 384.5  
Std dev 0.018 83.073  
Note: Diluted 2x 
Table B8: pKa values for R6G-A 
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Figure B25: Sample fluorescence spectra for R6G-DFA 
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Figure B26: Sample titration curve for R6G-DFA 
 
 
Figure B27: Sample UV-Vis spectra for R6G-DFA 
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R6G-DFA pKa Max fl intensity Fl lmax 
 4.26 607 553 
 4.27 683 553 
 4.30 591 553 
 4.29 601 553 
 4.32 551 553 
 4.28 564 553 
 4.37 584 553 
 4.33 704 553 
Mean 4.303 610.625  
Std dev 0.036 54.623  
Note: Diluted 2x 
Table B9: pKa values for R6G-DFA 
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Figure B28: Sample fluorescence spectra for R6G-DCA 
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Figure B29: Sample titration curve for R6G-DCA 
 
 
Figure B30: Sample UV-Vis spectra for R6G-DCA 
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R6G-DCA pKa Max fl intensity Fl lmax 
 5.64 644 551 
 5.59 590 551 
 5.58 656 551 
 5.64 663 551 
 5.58 650 551 
 5.64 463 551 
 5.59 647 551 
 5.69 639 551 
Mean 5.619 619  
Std dev 0.040 66.817  
Note: Diluted 2x 
Table B10: pKa values for R6G-DCA 
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Figure B31: Sample fluorescence spectra for R6G-DEA 
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Figure B32: Sample titration curve for R6G-DEA 
 
 
Figure B33: Sample UV-Vis spectra for R6G-DEA 
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R6G-DEA pKa Max fl intensity Fl lmax 
 4.13 136 552 
 4.10 133 552 
 4.21 227 552 
 4.15 83 552 
Mean 4.148 144.75 552 
Std dev 0.046 59.980  
Note: Diluted 2x 
Table B11: pKa values for R6G-DEA 
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Figure B34: Sample fluorescence spectra for R6G-DMA 
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Figure B35: Sample titration curve for R6G-DMA 
 
 
Figure B36: Sample UV-Vis spectra for R6G-DMA 
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R6G-DMA pKa Max fl intensity Fl lmax 
 5.29 882 552 
 5.21 824 552 
 5.28 537 552 
 5.33 495 552 
 5.30 551 552 
 5.44 503 552 
 5.36 809 552 
 5.36 763 552 
Mean 5.321 670.5  
Std dev 0.0683 163.442  
Note: Diluted 2x  
Table B12: pKa values for R6G-DMA 
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Figure B37: Sample fluorescence spectra for R6G-DIA 
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Figure B38: Sample titration curve for R6G-DIA 
 
 
Figure B39: Sample UV-Vis spectra for R6G-DIA 
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R6G-DIA pKa Max fl intensity Fl lmax 
 5.86 299 552 
 5.79 221 552 
 5.90 299 552 
 5.81 330 552 
 5.96 420 552 
 5.91 374 552 
Mean 5.872 323.833  
Std dev 0.064 68.718  
Note: Diluted 2x  
Table B13: pKa values for R6G-DIA 
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Figure B40: Sample fluorescence spectra for RB-4CA 
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Figure B41: Sample titration curve for RB-4CA 
 
 
Figure B42: Sample UV-Vis spectra for RB-4CA 
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RB-4CA pKa Max fl intensity Fl lmax 
 4.20 270 583 
 4.21 270 583 
 4.20 215 583 
 4.23 215 583 
Mean 4.21 242.500  
Std dev 0.014 31.754  
 
Table B14: pKa values for RB-4CA 
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Figure B43: Sample fluorescence spectra for RB-3,5CA 
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Figure B44: Sample titration curve for RB-3,5CA 
 
 
Figure B45: Sample UV-Vis spectra for RB-3,5CA 
 
 
 
 
 
232 
 
RB-3,5CA pKa Max fl intensity Fl lmax 
 4.30 485 587 
 4.36 478 587 
 4.35 291 587 
 4.36 493 587 
Mean 4.343 436.750  
Std dev 0.050 97.360  
 
Table B15: pKa values for RB-3,5CA 
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Figure B46: Sample fluorescence spectra for RB-DCNA 
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Figure B47: Sample titration curve for RB-DCNA 
 
 
 
Figure B48: Sample UV-Vis spectra for RB-DCNA 
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RB-DCNA pKa Max fl intensity Fl lmax 
 5.43
17
 - - 
 5.46 475 583 
 5.44 456 583 
 5.50 475 583 
Mean 5.458 468.667  
Std dev 0.031 10.970  
 
Table B16: pKa values for RB-DCNA 
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Figure B49: Sample fluorescence spectra for RB-2FA 
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Figure B50: Sample titration curve for RB-2FA 
 
 
Figure B51: Sample UV-Vis spectra for RB-2FA 
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RB-2FA pKa Max fl intensity Fl lmax 
 4.33 70 583 
 4.34 615 583 
 4.32 132 583 
Mean 4.33 272.333  
Std dev 0.01 298.373  
 
Table B17: pKa values for RB-2FA 
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Figure B52: Sample fluorescence spectra for RB-2CA 
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Figure B53: Sample titration curve for RB-2CA 
 
 
 
Figure B54: Sample UV-Vis spectra for RB-2CA 
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RB-2CA pKa Max fl intensity Fl lmax 
 4.35 79 585 
 4.45 103 585 
 4.49
18
 220 585 
Mean 4.43 134.000  
Std dev 0.072 75.439  
 
Table B18: pKa values for RB-2CA 
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 Titrated by Mona Rasooly 
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Figure B55: Sample fluorescence spectra for RB-2MA 
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Figure B56: Sample titration curve for RB-2MA 
 
 
 
Figure B57: Sample UV-Vis spectra for RB-2MA 
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RB-2MA pKa Max fl intensity Fl lmax 
 4.32
19 
249 583 
 4.31
19 
204 583 
 4.27
19
 219 583 
 4.32 191 583 
Mean 4.305 215.75  
Std dev 0.021 24.945  
 
Table B19: pKa values for RB-2MA 
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 Titrated by Mona Rasooly 
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Figure B58: Sample fluorescence spectra for RB-2IA 
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Figure B59: Sample titration curve for RB-2IA 
 
 
 
Figure B60: Sample UV-Vis spectra for RB-2IA 
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RB-2IA pKa Max fl intensity Fl lmax 
 4.28 245 582 
 4.30 234 582 
 4.26 234 582 
Mean 4.280 237.667  
Std dev 0.020 6.351  
 
Table B20: pKa values for RB-2IA 
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Appendix C 
Figure C1. RB and R6G pKa data for di-ortho substituents versus their Taft-Kutter-Hansch’s Es 
values 
 
 
 
 
Figure C2. RB and R6G pKa data for di-ortho substituents versus their Charton υ values 
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Figure C3. RB and R6G pKa data for di-ortho substituents versus their I
X-H
 kJ/mol values 
 
 
 
 
Figure C4. RB and R6G pKa data for di-ortho substituents versus their Meyer’s V
a
 values 
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Figure C5. RB and R6G pKa data for di-ortho substituents versus their σp values 
 
 
 
 
Figure C6. RB and R6G pKa data for di-ortho substituents versus their Traynham’s σo values 
 
 
 
 
 
3.5
4
4.5
5
5.5
6
-0.6 -0.4 -0.2 0 0.2 0.4 0.6
p
K
a 
σp 
pKa vs σp 
RB
R6G
3.5
4
4.5
5
5.5
6
-1 -0.5 0 0.5 1 1.5
p
K
a 
σo 
pKa vs Traynham's σo 
RB
R6G
251 
 
 
 
Figure C7. RB and R6G pKa data for di-ortho substituents versus their Swain-Lupton-Hansch’s 
F values 
 
 
 
 
Figure C8. RB and R6G pKa data for di-ortho substituents versus their Swain-Lupton’s R values 
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Figure C9. RB and R6G pKa data for di-ortho substituents versus their σI values 
 
 
 
 
Figure C10. R6G A-σp regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C11. R6G Es-σp regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C12. R6G υ-σp regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C13. R6G I
X-H
-σp regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C14. R6G V
a
 -σp regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C15. R6G A –σo regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C16. R6G Es –σo regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
R² = 0.9605 
3.5
4
4.5
5
5.5
6
6.5
3.5 4 4.5 5 5.5 6 6.5
P
re
d
ic
te
d
 p
K
a 
Experimental pKa 
R6G: A-σo Predicted pKa vs 
Experimental pKa 
R² = 0.9679 
3.5
4
4.5
5
5.5
6
6.5
3.5 4 4.5 5 5.5 6 6.5
P
re
d
ic
te
d
 p
K
a 
Experimental pKa 
R6G: Es-σo Predicted pKa vs 
Experimental pKa 
256 
 
 
 
Figure C17. R6G υ –σo regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C18. R6G I
X-H
 –σo regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C19. R6G V
a
 –σo regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
Figure C20. R6G A –F regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C21. R6G Es–F regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C22. R6G υ–R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C23. R6G I
X-H–R regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C24. R6G V
a–R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C25. R6G A–σI regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C26. R6G Es–σI regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C27. R6G Es–F-R regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C28. R6G Es–σI-R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C29. R6G Es–σI-F-R regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
Figure C30. R6G Es–σI
mod
-F-R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C31. RB A-σp regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C32. RB Es-σp regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C33. RB I
X-H
-σp regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C34. RB A-σo regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C35. RB Es-σo regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C36. RB I
X-H
-σo regression predicted pKa versus pKa of di-ortho derivatives 
 
 
R² = 0.8779 
3.5
4
4.5
5
5.5
6
6.5
3.5 4 4.5 5 5.5 6 6.5
P
re
d
ic
te
d
 p
K
a 
Experimental pKa 
RB: ES-σo Predicted pKa vs 
Experimental pKa 
R² = 0.789 
3.5
4
4.5
5
5.5
6
6.5
3.5 4 4.5 5 5.5 6 6.5
P
re
d
ic
te
d
 p
K
a 
Experimental pKa 
RB: IX-H-σo Predicted pKa vs 
Experimental pKa 
266 
 
 
 
 
Figure C37. RB υ-R regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C38. RB I
X-H
-R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C39. RB Es-σp-F regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C40. RB Es-F-R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C41. RB Es-σI-R regression predicted pKa versus pKa of di-ortho derivatives 
 
 
 
 
Figure C42. RB Es-σI-F-R regression predicted pKa versus pKa of di-ortho derivatives 
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Figure C43. RB pKa data for mono-ortho substituents versus their σI values 
 
 
 
 
Figure C44. RB pKa data for mono-ortho substituents versus their F values 
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Figure C45. RB pKa data for mono-ortho substituents versus their R values 
 
 
 
 
Figure C46. RB pKa data for mono-ortho substituents versus their V
a
 values 
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Figure C47. RB pKa data for mono-ortho substituents versus their Es values 
 
 
 
 
Figure C48. RB pKa data for mono-ortho substituents versus their A values 
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Figure C49. RB pKa data for mono-ortho substituents versus their υ values 
 
 
 
 
Figure C50. RB pKa data for mono-ortho substituents versus their I
X-H
 values 
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Figure C51. RB σp regression predicted pKa versus pKa of mono-ortho derivatives 
 
 
 
Figure C52. RB σI regression predicted pKa versus pKa of mono-ortho derivatives 
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Figure C53. RB σI
mod
-R regression predicted pKa versus pKa of mono-ortho derivatives 
 
 
 
Figure C54. RB F regression predicted pKa versus pKa of mono-ortho derivatives 
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Appendix D 
Note: All analyses performed by Dr. Robert D. Pike 
Table D1.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 
103) for RB-DIA.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________  
O(1) -1044(1) 284(1) 3277(1) 17(1) 
O(2) 2396(1) 2825(1) 4558(1) 27(1) 
N(1) -2332(1) -3025(1) 3970(1) 22(1) 
N(2) -2623(1) 3331(1) 2449(1) 24(1) 
N(3) 905(1) 1864(1) 4087(1) 15(1) 
C(1) -1310(1) -194(1) 3637(1) 15(1) 
C(2) -1646(2) -1328(1) 3628(1) 18(1) 
C(3) -2004(1) -1897(1) 3972(1) 18(1) 
C(4) -2047(2) -1262(1) 4319(1) 18(1) 
C(5) -1679(1) -142(1) 4318(1) 17(1) 
C(6) -1275(1) 426(1) 3979(1) 15(1) 
C(7) -845(1) 1652(1) 3974(1) 15(1) 
C(8) -1297(1) 2105(1) 3572(1) 15(1) 
C(9) -1761(1) 3211(1) 3508(1) 16(1) 
C(10) -2195(2) 3612(1) 3144(1) 18(1) 
C(11) -2191(2) 2917(1) 2812(1) 18(1) 
C(12) -1759(2) 1795(1) 2873(1) 17(1) 
C(13) -1344(1) 1417(1) 3246(1) 15(1) 
C(14) -1636(2) 2306(1) 4294(1) 15(1) 
C(15) -3254(2) 2436(1) 4354(1) 17(1) 
C(16) -3700(2) 3110(1) 4661(1) 19(1) 
C(17) -2551(2) 3644(1) 4902(1) 20(1) 
C(18) -937(2) 3507(1) 4841(1) 19(1) 
C(19) -506(2) 2824(1) 4535(1) 17(1) 
C(20) 1117(2) 2532(1) 4408(1) 18(1) 
C(21) 2240(1) 1463(1) 3871(1) 16(1) 
C(22) 2903(1) 413(1) 3965(1) 17(1) 
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C(23) 4197(2) 47(1) 3752(1) 19(1) 
C(24) 4829(2) 703(1) 3465(1) 19(1) 
C(25) 4215(2) 1753(1) 3390(1) 19(1) 
C(26) 2915(2) 2159(1) 3591(1) 17(1) 
C(27) 2398(2) -281(1) 4309(1) 23(1) 
C(28) 3636(2) -151(1) 4646(1) 31(1) 
C(29) 2165(2) -1512(1) 4205(1) 31(1) 
C(30) 2384(2) 3356(1) 3518(1) 20(1) 
C(31) 3601(2) 4161(1) 3710(1) 28(1) 
C(32) 2127(2) 3610(1) 3082(1) 27(1) 
C(33) -2494(2) -3640(1) 4335(1) 23(1) 
C(34) -4208(2) -3713(1) 4458(1) 30(1) 
C(35) -2032(2) -3698(1) 3629(1) 23(1) 
C(36) -266(2) -3971(1) 3590(1) 29(1) 
C(37) -2495(2) 2682(1) 2095(1) 33(1) 
C(38) -4002(3) 2062(2) 1978(1) 61(1) 
C(39) -3278(2) 4454(1) 2405(1) 25(1) 
C(40) -2017(2) 5355(1) 2386(1) 33(1) 
______________________________________________________________________________
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 Table D2.   Bond lengths [Å] and angles [°] for  RB-DIA 
_____________________________________________________  
O(1)-C(13)  1.3850(15) 
O(1)-C(1)  1.3869(14) 
O(2)-C(20)  1.2229(16) 
N(1)-C(3)  1.3805(17) 
N(1)-C(35)  1.4515(17) 
N(1)-C(33)  1.4611(17) 
N(2)-C(11)  1.3744(17) 
N(2)-C(37)  1.4488(18) 
N(2)-C(39)  1.4596(17) 
N(3)-C(20)  1.3663(16) 
N(3)-C(21)  1.4452(15) 
N(3)-C(7)  1.5239(15) 
C(1)-C(6)  1.3850(17) 
C(1)-C(2)  1.3887(18) 
C(2)-C(3)  1.4039(18) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.4133(18) 
C(4)-C(5)  1.3779(18) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.3987(17) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.5131(17) 
C(7)-C(8)  1.5141(16) 
C(7)-C(14)  1.5201(16) 
C(8)-C(13)  1.3891(17) 
C(8)-C(9)  1.3965(17) 
C(9)-C(10)  1.3734(18) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.4108(18) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.4073(18) 
C(12)-C(13)  1.3871(17) 
C(12)-H(12)  0.9500 
C(14)-C(19)  1.3808(18) 
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C(14)-C(15)  1.3867(17) 
C(15)-C(16)  1.3894(18) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.3992(19) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.3854(18) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.3887(18) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.4852(17) 
C(21)-C(26)  1.4064(18) 
C(21)-C(22)  1.4083(18) 
C(22)-C(23)  1.3996(18) 
C(22)-C(27)  1.5164(18) 
C(23)-C(24)  1.3795(19) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.3802(19) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.3971(18) 
C(25)-H(25)  0.9500 
C(26)-C(30)  1.5202(18) 
C(27)-C(29)  1.529(2) 
C(27)-C(28)  1.531(2) 
C(27)-H(27)  1.0000 
C(28)-H(28A)  0.9800 
C(28)-H(28B)  0.9800 
C(28)-H(28C)  0.9800 
C(29)-H(29A)  0.9800 
C(29)-H(29B)  0.9800 
C(29)-H(29C)  0.9800 
C(30)-C(32)  1.5305(19) 
C(30)-C(31)  1.5342(19) 
C(30)-H(30)  1.0000 
C(31)-H(31A)  0.9800 
C(31)-H(31B)  0.9800 
C(31)-H(31C)  0.9800 
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C(32)-H(32A)  0.9800 
C(32)-H(32B)  0.9800 
C(32)-H(32C)  0.9800 
C(33)-C(34)  1.5149(19) 
C(33)-H(33A)  0.9900 
C(33)-H(33B)  0.9900 
C(34)-H(34A)  0.9800 
C(34)-H(34B)  0.9800 
C(34)-H(34C)  0.9800 
C(35)-C(36)  1.5262(19) 
C(35)-H(35A)  0.9900 
C(35)-H(35B)  0.9900 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 
C(36)-H(36C)  0.9800 
C(37)-C(38)  1.507(3) 
C(37)-H(37A)  0.9900 
C(37)-H(37B)  0.9900 
C(38)-H(38A)  0.9800 
C(38)-H(38B)  0.9800 
C(38)-H(38C)  0.9800 
C(39)-C(40)  1.514(2) 
C(39)-H(39A)  0.9900 
C(39)-H(39B)  0.9900 
C(40)-H(40A)  0.9800 
C(40)-H(40B)  0.9800 
C(40)-H(40C)  0.9800 
 
C(13)-O(1)-C(1) 116.06(9) 
C(3)-N(1)-C(35) 120.53(11) 
C(3)-N(1)-C(33) 121.09(11) 
C(35)-N(1)-C(33) 115.62(10) 
C(11)-N(2)-C(37) 122.60(11) 
C(11)-N(2)-C(39) 120.74(11) 
C(37)-N(2)-C(39) 116.64(11) 
C(20)-N(3)-C(21) 121.77(10) 
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C(20)-N(3)-C(7) 113.40(9) 
C(21)-N(3)-C(7) 124.75(10) 
C(6)-C(1)-O(1) 122.04(11) 
C(6)-C(1)-C(2) 122.92(11) 
O(1)-C(1)-C(2) 115.02(11) 
C(1)-C(2)-C(3) 120.36(11) 
C(1)-C(2)-H(2) 119.8 
C(3)-C(2)-H(2) 119.8 
N(1)-C(3)-C(2) 121.46(11) 
N(1)-C(3)-C(4) 121.31(11) 
C(2)-C(3)-C(4) 117.22(11) 
C(5)-C(4)-C(3) 120.63(11) 
C(5)-C(4)-H(4) 119.7 
C(3)-C(4)-H(4) 119.7 
C(4)-C(5)-C(6) 122.59(12) 
C(4)-C(5)-H(5) 118.7 
C(6)-C(5)-H(5) 118.7 
C(1)-C(6)-C(5) 116.17(11) 
C(1)-C(6)-C(7) 120.65(11) 
C(5)-C(6)-C(7) 123.17(11) 
C(6)-C(7)-C(8) 107.87(10) 
C(6)-C(7)-C(14) 112.51(10) 
C(8)-C(7)-C(14) 111.61(10) 
C(6)-C(7)-N(3) 112.74(9) 
C(8)-C(7)-N(3) 112.17(9) 
C(14)-C(7)-N(3) 99.90(9) 
C(13)-C(8)-C(9) 115.94(11) 
C(13)-C(8)-C(7) 121.12(11) 
C(9)-C(8)-C(7) 122.88(11) 
C(10)-C(9)-C(8) 122.57(11) 
C(10)-C(9)-H(9) 118.7 
C(8)-C(9)-H(9) 118.7 
C(9)-C(10)-C(11) 121.17(11) 
C(9)-C(10)-H(10) 119.4 
C(11)-C(10)-H(10) 119.4 
N(2)-C(11)-C(12) 122.52(11) 
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N(2)-C(11)-C(10) 120.55(11) 
C(12)-C(11)-C(10) 116.91(11) 
C(13)-C(12)-C(11) 120.24(11) 
C(13)-C(12)-H(12) 119.9 
C(11)-C(12)-H(12) 119.9 
O(1)-C(13)-C(12) 115.43(11) 
O(1)-C(13)-C(8) 121.39(11) 
C(12)-C(13)-C(8) 123.12(11) 
C(19)-C(14)-C(15) 120.84(11) 
C(19)-C(14)-C(7) 110.85(10) 
C(15)-C(14)-C(7) 128.30(11) 
C(14)-C(15)-C(16) 118.02(12) 
C(14)-C(15)-H(15) 121.0 
C(16)-C(15)-H(15) 121.0 
C(15)-C(16)-C(17) 120.91(12) 
C(15)-C(16)-H(16) 119.5 
C(17)-C(16)-H(16) 119.5 
C(18)-C(17)-C(16) 120.77(12) 
C(18)-C(17)-H(17) 119.6 
C(16)-C(17)-H(17) 119.6 
C(17)-C(18)-C(19) 117.74(12) 
C(17)-C(18)-H(18) 121.1 
C(19)-C(18)-H(18) 121.1 
C(14)-C(19)-C(18) 121.71(12) 
C(14)-C(19)-C(20) 109.46(11) 
C(18)-C(19)-C(20) 128.83(12) 
O(2)-C(20)-N(3) 126.30(12) 
O(2)-C(20)-C(19) 127.34(12) 
N(3)-C(20)-C(19) 106.35(10) 
C(26)-C(21)-C(22) 121.40(11) 
C(26)-C(21)-N(3) 119.38(11) 
C(22)-C(21)-N(3) 119.08(11) 
C(23)-C(22)-C(21) 117.90(11) 
C(23)-C(22)-C(27) 118.47(11) 
C(21)-C(22)-C(27) 123.33(11) 
C(24)-C(23)-C(22) 121.18(12) 
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C(24)-C(23)-H(23) 119.4 
C(22)-C(23)-H(23) 119.4 
C(23)-C(24)-C(25) 120.14(12) 
C(23)-C(24)-H(24) 119.9 
C(25)-C(24)-H(24) 119.9 
C(24)-C(25)-C(26) 121.23(12) 
C(24)-C(25)-H(25) 119.4 
C(26)-C(25)-H(25) 119.4 
C(25)-C(26)-C(21) 118.01(12) 
C(25)-C(26)-C(30) 118.48(11) 
C(21)-C(26)-C(30) 123.35(11) 
C(22)-C(27)-C(29) 112.65(11) 
C(22)-C(27)-C(28) 109.25(11) 
C(29)-C(27)-C(28) 110.60(12) 
C(22)-C(27)-H(27) 108.1 
C(29)-C(27)-H(27) 108.1 
C(28)-C(27)-H(27) 108.1 
C(27)-C(28)-H(28A) 109.5 
C(27)-C(28)-H(28B) 109.5 
H(28A)-C(28)-H(28B) 109.5 
C(27)-C(28)-H(28C) 109.5 
H(28A)-C(28)-H(28C) 109.5 
H(28B)-C(28)-H(28C) 109.5 
C(27)-C(29)-H(29A) 109.5 
C(27)-C(29)-H(29B) 109.5 
H(29A)-C(29)-H(29B) 109.5 
C(27)-C(29)-H(29C) 109.5 
H(29A)-C(29)-H(29C) 109.5 
H(29B)-C(29)-H(29C) 109.5 
C(26)-C(30)-C(32) 112.22(11) 
C(26)-C(30)-C(31) 109.73(11) 
C(32)-C(30)-C(31) 111.03(11) 
C(26)-C(30)-H(30) 107.9 
C(32)-C(30)-H(30) 107.9 
C(31)-C(30)-H(30) 107.9 
C(30)-C(31)-H(31A) 109.5 
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C(30)-C(31)-H(31B) 109.5 
H(31A)-C(31)-H(31B) 109.5 
C(30)-C(31)-H(31C) 109.5 
H(31A)-C(31)-H(31C) 109.5 
H(31B)-C(31)-H(31C) 109.5 
C(30)-C(32)-H(32A) 109.5 
C(30)-C(32)-H(32B) 109.5 
H(32A)-C(32)-H(32B) 109.5 
C(30)-C(32)-H(32C) 109.5 
H(32A)-C(32)-H(32C) 109.5 
H(32B)-C(32)-H(32C) 109.5 
N(1)-C(33)-C(34) 112.77(11) 
N(1)-C(33)-H(33A) 109.0 
C(34)-C(33)-H(33A) 109.0 
N(1)-C(33)-H(33B) 109.0 
C(34)-C(33)-H(33B) 109.0 
H(33A)-C(33)-H(33B) 107.8 
C(33)-C(34)-H(34A) 109.5 
C(33)-C(34)-H(34B) 109.5 
H(34A)-C(34)-H(34B) 109.5 
C(33)-C(34)-H(34C) 109.5 
H(34A)-C(34)-H(34C) 109.5 
H(34B)-C(34)-H(34C) 109.5 
N(1)-C(35)-C(36) 112.71(12) 
N(1)-C(35)-H(35A) 109.0 
C(36)-C(35)-H(35A) 109.0 
N(1)-C(35)-H(35B) 109.0 
C(36)-C(35)-H(35B) 109.0 
H(35A)-C(35)-H(35B) 107.8 
C(35)-C(36)-H(36A) 109.5 
C(35)-C(36)-H(36B) 109.5 
H(36A)-C(36)-H(36B) 109.5 
C(35)-C(36)-H(36C) 109.5 
H(36A)-C(36)-H(36C) 109.5 
H(36B)-C(36)-H(36C) 109.5 
N(2)-C(37)-C(38) 113.61(15) 
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N(2)-C(37)-H(37A) 108.8 
C(38)-C(37)-H(37A) 108.8 
N(2)-C(37)-H(37B) 108.8 
C(38)-C(37)-H(37B) 108.8 
H(37A)-C(37)-H(37B) 107.7 
C(37)-C(38)-H(38A) 109.5 
C(37)-C(38)-H(38B) 109.5 
H(38A)-C(38)-H(38B) 109.5 
C(37)-C(38)-H(38C) 109.5 
H(38A)-C(38)-H(38C) 109.5 
H(38B)-C(38)-H(38C) 109.5 
N(2)-C(39)-C(40) 113.71(12) 
N(2)-C(39)-H(39A) 108.8 
C(40)-C(39)-H(39A) 108.8 
N(2)-C(39)-H(39B) 108.8 
C(40)-C(39)-H(39B) 108.8 
H(39A)-C(39)-H(39B) 107.7 
C(39)-C(40)-H(40A) 109.5 
C(39)-C(40)-H(40B) 109.5 
H(40A)-C(40)-H(40B) 109.5 
C(39)-C(40)-H(40C) 109.5 
H(40A)-C(40)-H(40C) 109.5 
H(40B)-C(40)-H(40C) 109.5 
_____________________________________________________________ 
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Table D3.  Torsion angles [°] for RB-DIA 
________________________________________________________________  
C(13)-O(1)-C(1)-C(6) -23.79(16) 
C(13)-O(1)-C(1)-C(2) 154.80(11) 
C(6)-C(1)-C(2)-C(3) 1.28(18) 
O(1)-C(1)-C(2)-C(3) -177.30(10) 
C(35)-N(1)-C(3)-C(2) 11.42(18) 
C(33)-N(1)-C(3)-C(2) 171.79(11) 
C(35)-N(1)-C(3)-C(4) -169.95(12) 
C(33)-N(1)-C(3)-C(4) -9.58(18) 
C(1)-C(2)-C(3)-N(1) -179.58(11) 
C(1)-C(2)-C(3)-C(4) 1.73(18) 
N(1)-C(3)-C(4)-C(5) 178.43(12) 
C(2)-C(3)-C(4)-C(5) -2.88(18) 
C(3)-C(4)-C(5)-C(6) 1.10(19) 
O(1)-C(1)-C(6)-C(5) 175.44(10) 
C(2)-C(1)-C(6)-C(5) -3.04(17) 
O(1)-C(1)-C(6)-C(7) -3.67(17) 
C(2)-C(1)-C(6)-C(7) 177.85(11) 
C(4)-C(5)-C(6)-C(1) 1.85(18) 
C(4)-C(5)-C(6)-C(7) -179.07(11) 
C(1)-C(6)-C(7)-C(8) 27.40(15) 
C(5)-C(6)-C(7)-C(8) -151.65(11) 
C(1)-C(6)-C(7)-C(14) 150.94(11) 
C(5)-C(6)-C(7)-C(14) -28.11(16) 
C(1)-C(6)-C(7)-N(3) -97.01(13) 
C(5)-C(6)-C(7)-N(3) 83.95(14) 
C(20)-N(3)-C(7)-C(6) -120.66(11) 
C(21)-N(3)-C(7)-C(6) 62.67(14) 
C(20)-N(3)-C(7)-C(8) 117.32(11) 
C(21)-N(3)-C(7)-C(8) -59.34(15) 
C(20)-N(3)-C(7)-C(14) -1.03(13) 
C(21)-N(3)-C(7)-C(14) -177.69(10) 
C(6)-C(7)-C(8)-C(13) -26.99(15) 
C(14)-C(7)-C(8)-C(13) -151.07(11) 
N(3)-C(7)-C(8)-C(13) 97.76(13) 
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C(6)-C(7)-C(8)-C(9) 149.95(11) 
C(14)-C(7)-C(8)-C(9) 25.87(16) 
N(3)-C(7)-C(8)-C(9) -85.30(13) 
C(13)-C(8)-C(9)-C(10) -1.82(18) 
C(7)-C(8)-C(9)-C(10) -178.92(11) 
C(8)-C(9)-C(10)-C(11) -0.11(19) 
C(37)-N(2)-C(11)-C(12) -7.2(2) 
C(39)-N(2)-C(11)-C(12) 171.26(12) 
C(37)-N(2)-C(11)-C(10) 174.02(13) 
C(39)-N(2)-C(11)-C(10) -7.50(19) 
C(9)-C(10)-C(11)-N(2) -179.78(12) 
C(9)-C(10)-C(11)-C(12) 1.38(18) 
N(2)-C(11)-C(12)-C(13) -179.49(12) 
C(10)-C(11)-C(12)-C(13) -0.68(18) 
C(1)-O(1)-C(13)-C(12) -153.04(10) 
C(1)-O(1)-C(13)-C(8) 24.21(16) 
C(11)-C(12)-C(13)-O(1) 175.84(11) 
C(11)-C(12)-C(13)-C(8) -1.35(19) 
C(9)-C(8)-C(13)-O(1) -174.47(10) 
C(7)-C(8)-C(13)-O(1) 2.67(17) 
C(9)-C(8)-C(13)-C(12) 2.56(17) 
C(7)-C(8)-C(13)-C(12) 179.71(11) 
C(6)-C(7)-C(14)-C(19) 121.63(11) 
C(8)-C(7)-C(14)-C(19) -116.94(11) 
N(3)-C(7)-C(14)-C(19) 1.82(12) 
C(6)-C(7)-C(14)-C(15) -59.82(16) 
C(8)-C(7)-C(14)-C(15) 61.61(16) 
N(3)-C(7)-C(14)-C(15) -179.63(12) 
C(19)-C(14)-C(15)-C(16) 0.60(18) 
C(7)-C(14)-C(15)-C(16) -177.83(11) 
C(14)-C(15)-C(16)-C(17) 0.20(18) 
C(15)-C(16)-C(17)-C(18) -0.5(2) 
C(16)-C(17)-C(18)-C(19) 0.06(19) 
C(15)-C(14)-C(19)-C(18) -1.10(19) 
C(7)-C(14)-C(19)-C(18) 177.58(11) 
C(15)-C(14)-C(19)-C(20) 179.31(11) 
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C(7)-C(14)-C(19)-C(20) -2.01(14) 
C(17)-C(18)-C(19)-C(14) 0.75(19) 
C(17)-C(18)-C(19)-C(20) -179.75(12) 
C(21)-N(3)-C(20)-O(2) -3.4(2) 
C(7)-N(3)-C(20)-O(2) 179.78(12) 
C(21)-N(3)-C(20)-C(19) 176.72(10) 
C(7)-N(3)-C(20)-C(19) -0.06(14) 
C(14)-C(19)-C(20)-O(2) -178.56(13) 
C(18)-C(19)-C(20)-O(2) 1.9(2) 
C(14)-C(19)-C(20)-N(3) 1.28(14) 
C(18)-C(19)-C(20)-N(3) -178.27(12) 
C(20)-N(3)-C(21)-C(26) -82.17(15) 
C(7)-N(3)-C(21)-C(26) 94.23(14) 
C(20)-N(3)-C(21)-C(22) 93.66(14) 
C(7)-N(3)-C(21)-C(22) -89.94(14) 
C(26)-C(21)-C(22)-C(23) -4.13(18) 
N(3)-C(21)-C(22)-C(23) -179.87(11) 
C(26)-C(21)-C(22)-C(27) 169.47(12) 
N(3)-C(21)-C(22)-C(27) -6.27(18) 
C(21)-C(22)-C(23)-C(24) 1.45(18) 
C(27)-C(22)-C(23)-C(24) -172.47(11) 
C(22)-C(23)-C(24)-C(25) 1.69(19) 
C(23)-C(24)-C(25)-C(26) -2.26(19) 
C(24)-C(25)-C(26)-C(21) -0.37(18) 
C(24)-C(25)-C(26)-C(30) 175.12(11) 
C(22)-C(21)-C(26)-C(25) 3.61(18) 
N(3)-C(21)-C(26)-C(25) 179.33(11) 
C(22)-C(21)-C(26)-C(30) -171.65(11) 
N(3)-C(21)-C(26)-C(30) 4.08(18) 
C(23)-C(22)-C(27)-C(29) -50.71(16) 
C(21)-C(22)-C(27)-C(29) 135.72(13) 
C(23)-C(22)-C(27)-C(28) 72.63(15) 
C(21)-C(22)-C(27)-C(28) -100.94(14) 
C(25)-C(26)-C(30)-C(32) 51.45(15) 
C(21)-C(26)-C(30)-C(32) -133.32(12) 
C(25)-C(26)-C(30)-C(31) -72.49(15) 
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C(21)-C(26)-C(30)-C(31) 102.74(14) 
C(3)-N(1)-C(33)-C(34) 93.38(15) 
C(35)-N(1)-C(33)-C(34) -105.35(13) 
C(3)-N(1)-C(35)-C(36) 76.94(15) 
C(33)-N(1)-C(35)-C(36) -84.44(14) 
C(11)-N(2)-C(37)-C(38) 92.72(17) 
C(39)-N(2)-C(37)-C(38) -85.82(17) 
C(11)-N(2)-C(39)-C(40) 84.85(15) 
C(37)-N(2)-C(39)-C(40) -96.58(15) 
________________________________________________________________  
 
